1. Cell Cycle/DNA Damage
    Cytoskeleton
  2. Microtubule/Tubulin

Vincristine sulfate (Synonyms: Leurocristine sulfate; 22-Oxovincaleukoblastine sulfate)

Cat. No.: HY-N0488 Purity: 99.40%
Data Sheet SDS Handling Instructions

Vincristine (sulfate) is an inhibitor of polymerization of microtubules by binding to tubulin with IC50 of 32 μM in a cell-free assay.

For research use only. We do not sell to patients.
Vincristine sulfate Chemical Structure

Vincristine sulfate Chemical Structure

CAS No. : 2068-78-2

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply now  
10 mM * 1 mL in DMSO $55 In-stock
10 mg $50 In-stock
50 mg $110 In-stock
100 mg $180 In-stock
200 mg $330 In-stock
500 mg   Get quote  
1 g   Get quote  

* Please select Quantity before adding items.

  • Biological Activity

  • Protocol

  • Technical Information

  • Purity & Documentation

  • References

Description

Vincristine (sulfate) is an inhibitor of polymerization of microtubules by binding to tubulin with IC50 of 32 μM in a cell-free assay.

In Vitro

Vincristine inhibits net addition of tubulin dimers at assembly ends of steady-state microtubules with Ki of 85 nM[1]. Vincristine stabilizes the spindle apparatus resulting in failure of the chromosomes to segregate leading to metaphase arrest and inhibition of mitosis at low concentrations. At higher concentrations, Vincristine may disrupt and induce total depolymerization of microtubules[2]. Vincristine induces apoptosis in tumor cells and inhibits SH-SY5Y cell proliferation with IC50 of 0.1 μM. Vincristine induces mitotic arrest and promots the expression of caspase-3 and -9 and cyclin B, while decreasing the expression of cyclin D[3]. Vincristine induced neurotoxicity is caused by interference with microtubule function, which results in blockage of axonal transport and thus in axonal degeneration[4]

In Vivo

Vincristine (3 mg/kg, i.p.) induces mean growth delay of > 120 and > 52 day, and repopulates fractions of 0.06% and 5%, administrated in mice bearing bilateral subcutaneous xenografts Rh12 or Rh18, respectively[5]

Clinical Trial
NCT Number Sponsor Condition Start Date Phase
NCT00038207 M.D. Anderson Cancer Center|Inex Pharmaceuticals Soft Tissue Sarcoma|Lymphoma|Leukemia|Wilms' Tumor|Osteosarcoma June 2000 Phase 2
NCT02072785 Nanjing Luye Sike Pharmaceutical Co.,Ltd.|Ethics Committee of Blood Diseases Hospital|Guangdong General Hospital|Qilu Hospital of Shandong University|Xijing Hospital|Xinqiao Hospital of Chongqing|China Medical University, China|West China Hospital|Second Affiliated Hospital of Xi'an Jiaotong University|The Second Hospital of Hebei Medical University|The First Affiliated Hospital of Zhengzhou University|Nanfang Hospital of Southern Medical University|First Affiliated Hospital of Harbin Medical University|Xuzhou Medical University|First Affiliated Hospital of Zhejiang University Adult Acute Lymphoblastic Leukemia June 2013 Phase 3
NCT00555464 Medical College of Wisconsin|FDA Office of Orphan Products Development Hemangioma November 2007 Phase 2
NCT01355445 Centre Oscar Lambret|SFCE RHABDOMYOSARCOMA January 2012 Phase 2
NCT02110069 Boston Children’s Hospital|Pfizer Kaposiform Hemangioendothelioma (KHE)|Kasabach-Merritt Syndrome|Tufted Angioma June 14, 2017 Phase 2
NCT02337478 Wake Forest University Health Sciences|National Cancer Institute (NCI)|Spectrum Pharmaceuticals, Inc Recurrent Adult Acute Myeloid Leukemia May 2015 Phase 2
NCT01397825 Millennium Pharmaceuticals, Inc.|Takeda Diffuse Large B-Cell Lymphoma|Transformed Follicular Lymphoma|Mantle Cell Lymphoma|Burkitt's Lymphoma August 2011 Phase 1|Phase 2
NCT00022555 National Cancer Institute (NCI) AIDS-related Diffuse Large Cell Lymphoma|AIDS-related Diffuse Mixed Cell Lymphoma|AIDS-related Peripheral/Systemic Lymphoma|AIDS-related Small Noncleaved Cell Lymphoma November 2001 Phase 1
NCT00145041 Spectrum Pharmaceuticals, Inc Malignant Melanoma February 2005 Phase 1
NCT00058305 National Cancer Institute (NCI) Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma March 2003 Phase 2
NCT02861040 Northwestern University|National Comprehensive Cancer Network|National Cancer Institute (NCI) Recurrent Adult Acute Lymphoblastic Leukemia|Refractory Adult Acute Lymphoblastic Leukemia August 2016 Phase 1
NCT00003166 National Cancer Institute (NCI) Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Multiple Myeloma|Stage III Multiple Myeloma May 1998 Phase 1
NCT00495079 Spectrum Pharmaceuticals, Inc|Parexel Acute Lymphoblastic Leukemia (ALL) May 2007 Phase 2
NCT00901069 Shams Shakil|Celgene|University of Kentucky Lymphoma|Hodgkin Disease|Lymphoma, Non-Hodgkin May 2009 Phase 1
NCT00144963 Spectrum Pharmaceuticals, Inc Acute Lymphoblastic Leukemia July 2002 Phase 1|Phase 2
NCT01439347 Spectrum Pharmaceuticals, Inc Acute Lymphoblastic Leukemia (ALL) March 2012 Phase 3
NCT00933985 National Cancer Institute (NCI) Acute Leukemias of Ambiguous Lineage|Acute Undifferentiated Leukemia|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Nasal Type Extranodal NK/T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Recur June 2009 Phase 1
NCT00077207 Children's Oncology Group|National Cancer Institute (NCI) Brain Tumor|Central Nervous System Tumor July 2004
NCT00184002 University of Southern California|Ortho Biotech, Inc. Non-Hodgkin's Lymphoma January 10, 2003 Phase 2
NCT02163356 South Plains Oncology Consortium|EVAN Foundation Recurrent Neuroblastoma|Neuroblastoma May 2014 Phase 1
NCT02257242 Adam Olszewski|Spectrum Pharmaceuticals, Inc|Rhode Island Hospital|The Miriam Hospital|Brown University Lymphoma, Non-Hodgkin|Lymphoma, Follicular|Lymphoma, Mantle-Cell|Lymphoma, Small-Cell|Waldenstrom Macroglobulinemia|Lymphoma, B-Cell, Marginal Zone May 10, 2017 Phase 1
NCT00001689 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Acute Lymphocytic Leukemia|Leukemia January 1998 Phase 1
NCT00718757 St. Jude Children's Research Hospital Non-Hodgkins Lymphoma|Hodgkin's Disease|Acute Lymphoblastic Leukemia January 2005 Phase 1
NCT00038142 M.D. Anderson Cancer Center Ewing's Sarcoma November 1997 Phase 2
NCT00980551 Children's Hospital Medical Center, Cincinnati Retinoblastoma May 2010
NCT00503594 Assistance Publique - Hôpitaux de Paris|French Innovative Leukemia Organisation Lymphoma July 2007 Phase 2
NCT00506142 Spectrum Pharmaceuticals, Inc Metastatic Malignant Uveal Melanoma November 2007 Phase 2
NCT00763763 Assistance Publique - Hôpitaux de Paris Leukemia, Lymphocytic, Acute|Philadelphia Chromosome|Blast Crisis|Leukemia, Myeloid, Chronic December 2004 Phase 2
NCT00509353 Children's Hospital Los Angeles|National Cancer Institute (NCI) Neuroblastoma January 2007 Phase 1
NCT01887587 Ehab L Atallah|Medical College of Wisconsin Relapsed or Refractory Acute Lymphoblastic Leukemia|Relapsed or Refractory Lymphoblastic Lymphoma|Mixed Phenotype Acute Leukemia October 2013 Phase 1
NCT00138216 Children's Oncology Group|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Unspecified Childhood Solid Tumor, Protocol Specific October 2005 Phase 1
NCT03136146 M.D. Anderson Cancer Center Hematopoietic/Lymphoid Cancer|Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|Burkitt Leukemia/Lymphoma September 2017 Phase 2
NCT00006383 Inex Pharmaceuticals|National Cancer Institute (NCI) Lymphoma June 2000 Phase 2
NCT00392340 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Neuroblastoma March 2008 Phase 2
NCT00344422 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA Multiple Myeloma|Myeloma|M-Protein|Myeloma Proteins October 2000 Phase 3
NCT00905034 M.D. Anderson Cancer Center|Leadiant Biosciences, Inc. Leukemia, Lymphocytic, Acute March 2009 Phase 2
NCT00411541 International BFM Study Group|Associazione Italiana Ematologia Oncologia Pediatrica|BFM-A, Austria|BFM-G, Germany and Switzerland|CPH, Czech republic|European Organisation for Research and Treatment of Cancer - EORTC|GATLA, Argentina|H-POG, Hungary|PINDA, Chile Acute Lymphoblastic Leukemia April 1995 Phase 4
NCT00516295 National Cancer Institute (NCI) Ewing Sarcoma of Bone|Extraosseous Ewing Sarcoma|Peripheral Primitive Neuroectodermal Tumor|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor February 2008 Phase 2
NCT00596154 Memorial Sloan Kettering Cancer Center CNS Lymphoma|CNS Brain Cancer|Non-Hodgkin's Lymphoma December 2004 Phase 2
NCT00059839 Children's Oncology Group|National Cancer Institute (NCI) Lymphoma November 2003 Phase 3
NCT00491946 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Cancer June 2004 Phase 4
NCT00441168 Janssen-Cilag International NV Multiple Myeloma December 2006 Phase 2
NCT00186979 St. Jude Children's Research Hospital|AstraZeneca|National Institutes of Health (NIH) Solid Tumors May 2003 Phase 1
NCT00075582 Children's Oncology Group|National Cancer Institute (NCI) Adult Rhabdomyosarcoma|Embryonal Childhood Rhabdomyosarcoma|Embryonal-botryoid Childhood Rhabdomyosarcoma|Previously Untreated Childhood Rhabdomyosarcoma September 2004 Phase 3
NCT02135874 M.D. Anderson Cancer Center Leukemia October 2014 Phase 2
NCT00001339 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Adrenal Cortical Carcinoma August 1993 Phase 2
NCT01478542 University Hospital, Saarland|German High-Grade Non-Hodgkin's Lymphoma Study Group CD20+ Aggressive B-Cell Lymphoma November 2011 Phase 3
NCT00003203 Children's Oncology Group|National Cancer Institute (NCI) Brain Tumors|Central Nervous System Tumors|Neuroblastoma March 1998 Phase 2
NCT00381680 Children's Oncology Group|National Cancer Institute (NCI) B-cell Childhood Acute Lymphoblastic Leukemia|L1 Childhood Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia March 2007 Phase 3
NCT00002105 Sequus Pharmaceuticals|NIH AIDS Clinical Trials Information Service Sarcoma, Kaposi|HIV Infections Phase 3
NCT00201695 Ohio State University Comprehensive Cancer Center Multiple Myeloma July 2004 Phase 2
NCT00993044 Children's Hospital Los Angeles Refractory Solid Tumors in Children September 2009 Phase 1
NCT00006095 Children's Oncology Group|National Cancer Institute (NCI) Unspecified Childhood Solid Tumor, Protocol Specific July 2000 Phase 1
NCT00001059 National Institute of Allergy and Infectious Diseases (NIAID)|Sequus Pharmaceuticals|Amgen Sarcoma, Kaposi|HIV Infections Phase 2
NCT03023046 University of Washington|National Cancer Institute (NCI) Adult Acute Lymphoblastic Leukemia|Adult Lymphoblastic Lymphoma|Philadelphia Chromosome Positive February 23, 2017 Phase 2
NCT01735747 Rongjie Tao|National Natural Science Foundation of China|Shandong Cancer Hospital and Institute Central Nervous System Tumors June 2008 Phase 2
NCT01855750 Janssen Research & Development, LLC|Pharmacyclics LLC. Lymphoma September 3, 2013 Phase 3
NCT00002318 Sequus Pharmaceuticals|NIH AIDS Clinical Trials Information Service Sarcoma, Kaposi|HIV Infections Phase 3
NCT02538926 University of Washington|National Cancer Institute (NCI) B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent B Lymphoblastic Lymphoma|Recurrent T Lymphoblastic Leukemia/Lymphoma|Refractory B Lymphoblastic Lymphoma|Refractory T Lymphoblastic Lymphoma|T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma July 1, 2017 Phase 2
NCT01974440 Janssen Research & Development, LLC|Pharmacyclics LLC. Lymphoma January 31, 2014 Phase 3
NCT00080847 National Cancer Institute (NCI) Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma March 2004 Phase 2
NCT01527149 Roswell Park Cancer Institute|National Cancer Institute (NCI)|National Comprehensive Cancer Network Stage I Mantle Cell Lymphoma|Stage II Contiguous Mantle Cell Lymphoma|Stage II Non-Contiguous Mantle Cell Lymphoma|Stage III Mantle Cell Lymphoma|Stage IV Mantle Cell Lymphoma December 6, 2011 Phase 2
NCT00002093 Nexstar Pharmaceuticals|NIH AIDS Clinical Trials Information Service Sarcoma, Kaposi|HIV Infections Phase 3
NCT01399372 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|NRG Oncology Chemotherapeutic Agent Toxicity|Cognitive/Functional Effects|Lymphoma|Neurotoxicity|Radiation Toxicity September 2011 Phase 2
NCT00774202 Weill Medical College of Cornell University|Biogen|Genentech, Inc. Immune Thrombocytopenic Purpura November 2003 Phase 2|Phase 3
NCT02566993 PharmaMar Small-cell Lung Cancer July 2016 Phase 3
NCT00079417 Children's Oncology Group|National Cancer Institute (NCI) Intraocular Retinoblastoma December 2005 Phase 3
NCT01040871 Millennium Pharmaceuticals, Inc.|Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Diffuse Large B-Cell Lymphoma January 2010 Phase 2
NCT01463852 Dartmouth-Hitchcock Medical Center Chronic Lymphocytic Leukemia (CLL) October 2012 Early Phase 1
NCT00000681 National Institute of Allergy and Infectious Diseases (NIAID) Sarcoma, Kaposi|HIV Infections Phase 1
NCT00335738 Children's Oncology Group|National Cancer Institute (NCI) Intraocular Retinoblastoma December 2005 Phase 3
NCT02035137 New Approaches to Neuroblastoma Therapy Consortium Neuroblastoma July 2014 Phase 2
NCT00003935 Children's Oncology Group|National Cancer Institute (NCI) Brain Tumors|Central Nervous System Tumors September 1999 Phase 1
NCT01851551 Spectrum Pharmaceuticals, Inc Non-Hodgkin's Lymphoma|Diffuse Large B-cell Lymphoma|Mantle Cell Lymphoma September 2001 Phase 1|Phase 2
NCT01324180 H. Lee Moffitt Cancer Center and Research Institute|Pediatric Cancer Foundation Acute Lymphoblastic Leukemia July 18, 2011 Phase 1
NCT00003847 Vertex Pharmaceuticals Incorporated Lung Cancer December 1998 Phase 2
NCT00541411 King Faisal Specialist Hospital & Research Center Ewing's Sarcoma June 2003
NCT01528046 H. Lee Moffitt Cancer Center and Research Institute|Pediatric Cancer Foundation Solid Tumors|Primary Brain Tumors April 25, 2012 Phase 1
NCT01313884 Stanford University|Amgen Bone Cancer|Ewing's Sarcoma May 2011 Phase 2
NCT00669877 M.D. Anderson Cancer Center Burkitt's Lymphoma|Burkitt'S-like Lymphoma August 2002 Phase 2
NCT00002794 St. Jude Children's Research Hospital|National Cancer Institute (NCI) Retinoblastoma February 1996 Phase 2
NCT00278421 German High-Grade Non-Hodgkin's Lymphoma Study Group Lymphoma November 2005 Phase 3
NCT00494780 GlaxoSmithKline Lymphoma, Follicular June 2007 Phase 2
NCT01427114 Konkuk University Medical Center|Seoul St. Mary's Hospital Lymphoma July 2011 Phase 2
NCT00722137 Millennium Pharmaceuticals, Inc.|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Takeda Mantle Cell Lymphoma May 2008 Phase 3
NCT00002463 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Brain and Central Nervous System Tumors February 1989 Phase 2
NCT00352534 Children's Oncology Group|National Cancer Institute (NCI) Stage I Wilms Tumor|Stage II Wilms Tumor|Stage III Wilms Tumor October 2006 Phase 3
NCT00110110 The Hospital for Sick Children|Terry Fox Foundation Retinoblastoma June 2004 Phase 2
NCT02595242 CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Diffuse Large B Cell Lymphoma June 2015 Phase 1
NCT00245089 Japan Rhabdomyosarcoma Study Group|National Cancer Institute (NCI) Sarcoma May 2004 Phase 2
NCT01925131 Southwest Oncology Group|National Cancer Institute (NCI) Acute Leukemias of Ambiguous Lineage|B-cell Adult Acute Lymphoblastic Leukemia|Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Burkitt Lymphoma April 2014 Phase 1
NCT00215943 H. Lee Moffitt Cancer Center and Research Institute|Novartis Multiple Myeloma June 2003 Phase 3
NCT00002804 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma September 1996 Phase 2
NCT00278408 German High-Grade Non-Hodgkin's Lymphoma Study Group Lymphoma November 2005 Phase 3
NCT02455245 Natasha Pillay Smiley|Ann & Robert H Lurie Children's Hospital of Chicago Low Grade Glioma March 2015 Phase 3
NCT03220022 National Cancer Institute (NCI) AIDS-Related Lymphoma|CD20 Positive|HIV Positivity|Stage II Diffuse Large B-Cell Lymphoma|Stage III Diffuse Large B-Cell Lymphoma|Stage IV Diffuse Large B-Cell Lymphoma November 1, 2017 Phase 1
NCT00786669 Children's Hospital Medical Center, Cincinnati Solid Tumor October 2008 Phase 1
NCT00072384 Children's Oncology Group|National Cancer Institute (NCI) Intraocular Retinoblastoma April 2007 Phase 3
NCT01009970 Fondazione Italiana Linfomi ONLUS Diffuse Large B-Cell Lymphoma May 2010 Phase 2
NCT00354835 Children's Oncology Group|National Cancer Institute (NCI) Adult Malignant Mesenchymoma|Adult Rhabdomyosarcoma|Childhood Alveolar Rhabdomyosarcoma|Childhood Botryoid-Type Embryonal Rhabdomyosarcoma|Childhood Embryonal Rhabdomyosarcoma|Childhood Malignant Mesenchymoma|Non-Metastatic Childhood Soft Tissue Sarcoma|Stage I Adult Soft Tissue Sarcoma|Stage II Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Untreated Childhood Rhabdomyosarcoma December 2006 Phase 3
NCT02199184 M.D. Anderson Cancer Center Leukemia January 2015 Phase 2
NCT00971763 University College, London Lymphoma March 2006 Phase 2
NCT00245141 Japan Rhabdomyosarcoma Study Group|National Cancer Institute (NCI) Sarcoma May 2004 Phase 2
NCT01403415 National Cancer Institute (NCI) Childhood B Acute Lymphoblastic Leukemia|Childhood T Acute Lymphoblastic Leukemia|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Lymphoblastic Lymphoma September 2011 Phase 1
NCT00877006 Teva Branded Pharmaceutical Products, R&D Inc.|Teva Pharmaceutical Industries Non-Hodgkin's Lymphoma|Mantle Cell Lymphoma April 30, 2009 Phase 3
NCT00003015 Societe Internationale d'Oncologie Pediatrique|National Cancer Institute (NCI) Brain and Central Nervous System Tumors January 1997 Phase 3
NCT00193479 SCRI Development Innovations, LLC|Genentech, Inc.|Amgen Non-Hodgkins Lymphoma April 2003 Phase 2
NCT02428751 Wenqi Jiang|Sun Yat-sen University Lymphoma, Large B-Cell, Diffuse September 2015 Phase 3
NCT00911183 Institut Bergonié|National Cancer Institute (NCI) Lymphoma October 2008 Phase 2
NCT01231906 Children's Oncology Group|National Cancer Institute (NCI) Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)|Childhood Supratentorial Primitive Neuroectodermal Tumor|Ewing Sarcoma of Bone|Extraosseous Ewing Sarcoma|Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Peripheral Primitive Neuroectodermal Tumor of the Kidney|Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor November 2010 Phase 3
NCT02518750 St. Jude Children's Research Hospital|Novartis Pharmaceuticals|Spectrum Pharmaceuticals, Inc Acute Lymphoblastic Leukemia|Lymphoma, Non-Hodgkin's|Leukemia, T-Cell|Leukemia, B-Cell November 23, 2016 Phase 2
NCT00428142 NCIC Clinical Trials Group|Canadian Cancer Trials Group Lymphoma December 2006 Phase 2
NCT00003493 The Cleveland Clinic|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm November 1998 Phase 2
NCT01527422 Fernando Cabanillas|Genzyme, a Sanofi Company|Auxilio Mutuo Cancer Center Lymphoma|Non Hodgkin's Lymphoma January 2006 Phase 1|Phase 2
NCT00354744 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma July 2006 Phase 3
NCT00003958 Children's Oncology Group|National Cancer Institute (NCI) Adult Malignant Mesenchymoma|Adult Rhabdomyosarcoma|Alveolar Childhood Rhabdomyosarcoma|Childhood Malignant Mesenchymoma|Embryonal Childhood Rhabdomyosarcoma|Embryonal-botryoid Childhood Rhabdomyosarcoma|Nonmetastatic Childhood Soft Tissue Sarcoma|Previously Untreated Childhood Rhabdomyosarcoma|Stage I Adult Soft Tissue Sarcoma|Stage II Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma September 2002 Phase 3
NCT00070018 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma February 2004 Phase 2
NCT01856192 National Cancer Institute (NCI) CD20 Positive|Stage II Diffuse Large B-Cell Lymphoma|Stage III Diffuse Large B-Cell Lymphoma|Stage IV Diffuse Large B-Cell Lymphoma August 27, 2013 Phase 2
NCT00427570 NSABP Foundation Inc|National Cancer Institute (NCI) Colorectal Cancer September 1977 Phase 3
NCT00334867 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma December 2005 Phase 3
NCT00003625 Children's Oncology Group|National Cancer Institute (NCI) Brain Tumors|Central Nervous System Tumors December 1998 Phase 1
NCT00107380 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma November 2005 Phase 2
NCT00313053 Clare Twist|National Institutes of Health (NIH)|Stanford University Leukemia, Lymphocytic, Acute|Leukemia|Acute Lymphoid Leukemia (ALL) September 2004 Phase 1
NCT00003490 The Cleveland Clinic|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm October 1998 Phase 2
NCT00052455 Institute of Cancer Research, United Kingdom|National Cancer Institute (NCI) Brain and Central Nervous System Tumors October 2002 Phase 3
NCT00544219 Swiss Group for Clinical Cancer Research Lymphoma September 2007
NCT02567435 National Cancer Institute (NCI) Alveolar Rhabdomyosarcoma|Botryoid-Type Embryonal Rhabdomyosarcoma|Embryonal Rhabdomyosarcoma|Rhabdomyosarcoma|Sclerosing Rhabdomyosarcoma|Spindle Cell Rhabdomyosarcoma|Untreated Childhood Rhabdomyosarcoma May 23, 2016 Phase 3
NCT00770224 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma April 2009 Phase 2
NCT00000954 National Institute of Allergy and Infectious Diseases (NIAID)|Novum|Bristol-Myers Squibb Sarcoma, Kaposi|HIV Infections Phase 1
NCT00726700 German High-Grade Non-Hodgkin's Lymphoma Study Group|National Cancer Institute (NCI) Lymphoma May 2004 Phase 2
NCT00276666 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Brain and Central Nervous System Tumors November 2001 Phase 2
NCT00313079 Steven E. Coutre|Stanford University Leukemia, Lymphocytic|Leukemia|Acute Lymphocytic Leukemia May 2006 Phase 1
NCT00274911 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Brain and Central Nervous System Tumors February 2004 Phase 2
NCT00500890 M.D. Anderson Cancer Center Choroid Plexus Tumors September 2005 Phase 3
NCT02143414 National Cancer Institute (NCI) B Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative|Philadelphia Chromosome Positive|Recurrent Adult Acute Lymphoblastic Leukemia|Refractory Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia January 12, 2015 Phase 2
NCT00070083 British Columbia Cancer Agency|National Cancer Institute (NCI) Lymphoma July 2003 Phase 1
NCT01837862 Mark Atlas|Janssen Pharmaceuticals|Northwell Health Pilomyxoid Astrocytoma|Pilocytic Astrocytoma|Glioma, Astrocytic|Optic Nerve Glioma|Pleomorphic Xanthoastrocytoma|Glioblastoma Multiforme|Anaplastic Astrocytoma|Gliosarcoma|Diffuse Intrinsic Pontine Glioma|DIPG|Low-grade Glioma|Brainstem Glioma April 2015 Phase 1|Phase 2
NCT00004010 Children's Oncology Group|National Cancer Institute (NCI) Lymphoma October 1999 Phase 2
NCT00671658 M.D. Anderson Cancer Center Leukemia|Acute Lymphoblastic Leukemia November 2002 Phase 2
NCT00262925 National Cancer Institute (NCI) Recurrent Adult Acute Lymphoblastic Leukemia June 2006 Phase 2
NCT02055820 Hoffmann-La Roche|AbbVie Lymphoma, Non-Hodgkin November 17, 2013 Phase 1|Phase 2
NCT00025363 National Cancer Institute (NCI) Alveolar Childhood Rhabdomyosarcoma|Embryonal Childhood Rhabdomyosarcoma|Embryonal-botryoid Childhood Rhabdomyosarcoma|Previously Treated Childhood Rhabdomyosarcoma|Recurrent Childhood Rhabdomyosarcoma November 2001 Phase 2
NCT01542736 University of Colorado, Denver Metastatic Medulloblastoma|High Risk Supratentorial PNET|Metastatic PNET May 2007 Phase 2
NCT00079261 European Organisation for Research and Treatment of Cancer - EORTC Lymphoma|Small Intestine Cancer January 2004 Phase 2
NCT01925612 Seattle Genetics, Inc. Lymphoma, B-cell|Lymphoma, Large B-cell, Diffuse August 2013 Phase 2
NCT02792491 Pusan National University Hospital Diffuse Large B-cell Lymphoma August 2012 Phase 2
NCT01055496 Pfizer|UCB Pharma Lymphoma, B-Cell March 2010 Phase 1
NCT00070447 National Cancer Institute (NCI) Lymphoma November 2003 Phase 2
NCT03003520 Celgene Lymphoma, Large B-Cell, Diffuse February 28, 2017 Phase 2
NCT00450801 University of Miami Lymphoma April 2004 Phase 2
NCT00878254 University of Miami Mantle-Cell Lymphoma March 25, 2009 Phase 2
NCT00003388 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lymphoma February 1999 Phase 2
NCT00141648 Trans-Tasman Radiation Oncology Group (TROG)|Australasian Leukaemia and Lymphoma Group|Australasian Radiation Oncology Lymphoma Group|Wesley Research Institute Osteolymphoma September 2000
NCT00121199 National Cancer Institute (NCI) Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma June 2005 Phase 2
NCT00337987 Yale University|Eisai Inc. Peripheral T-Cell Lymphoma November 2005 Phase 2
NCT02677116 Eli Lilly and Company Neoplasm Metastasis August 2016 Phase 1
NCT00052936 German High-Grade Non-Hodgkin's Lymphoma Study Group|National Cancer Institute (NCI) Lymphoma January 2001 Phase 3
NCT00670358 Mayo Clinic|National Cancer Institute (NCI) Lymphoma August 2008 Phase 1|Phase 2
NCT00002806 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Brain and Central Nervous System Tumors July 1996 Phase 2
NCT00900445 Children's Oncology Group|National Cancer Institute (NCI) Leukemia June 2008
NCT00000987 National Institute of Allergy and Infectious Diseases (NIAID) Sarcoma, Kaposi|HIV Infections Phase 1
NCT01336933 University of Nebraska|National Cancer Institute (NCI)|Spectrum Pharmaceuticals, Inc Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Hepatosplenic T-cell Lymphoma|Peripheral T-cell Lymphoma July 2011 Phase 2
NCT00002766 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Leukemia|Lymphoma March 1996 Phase 3
NCT00001209 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Neuroectodermal Tumor, Primitive|Neuroepithelioma|Osteosarcoma|Sarcoma|Sarcoma, Ewing's October 1986 Phase 1
NCT00002536 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Cancer December 1996 Phase 3
NCT00634179 Emory University|Millennium Pharmaceuticals, Inc. Lymphoma, B-Cell|Follicular Lymphoma February 2008 Phase 1|Phase 2
NCT02889523 The Lymphoma Academic Research Organisation|Epizyme, Inc. Lymphoma, Large B-Cell, Diffuse October 2016 Phase 1|Phase 2
NCT00250718 New Mexico Cancer Care Alliance Non-Hodgkin's Lymphoma|Cancer October 2004 Phase 2
NCT00002840 European Organisation for Research and Treatment of Cancer - EORTC|Medical Research Council Brain and Central Nervous System Tumors August 1996 Phase 3
NCT02855359 Seattle Genetics, Inc. Diffuse, Large B-Cell, Lymphoma|Follicular Lymphoma, Grade 3b|Transformed Lymphoma / DLBCL August 2016 Phase 2
NCT02636322 M.D. Anderson Cancer Center|Celgene|Janssen Scientific Affairs, LLC Lymphoma March 2016 Phase 2
NCT00877110 Memorial Sloan Kettering Cancer Center Neuroblastoma|Bone Marrow, Sympathetic Nervous System April 2, 2009 Phase 1
NCT01371630 M.D. Anderson Cancer Center|Pfizer Leukemia|Acute Lymphoblastic Leukemia August 2011 Phase 1|Phase 2
NCT02017964 Children's Oncology Group|National Cancer Institute (NCI) Untreated Childhood Medulloblastoma December 2013 Phase 2
NCT00276640 Societe Internationale d'Oncologie Pediatrique Primary Central Nervous System Neoplasms April 2004
NCT00787527 M.D. Anderson Cancer Center|Merck Sharp & Dohme Corp. Lymphoma November 2008 Phase 1|Phase 2
NCT02359162 Sun Yat-sen University Lymphoma, Extranodal NK-T-Cell May 2015 Phase 3
NCT01719835 Royal Marsden NHS Foundation Trust|Cancer Research UK Peripheral T-cell Lymphoma NOS|Anaplastic Large Cell Lymphoma, ALK-Negative|Angioimmunoblastic T-cell Lymphoma|Hepatosplenic Gamma/ Delta T-cell Lymphoma March 2012 Phase 2
NCT00379574 Asan Medical Center|Janssen Korea, Ltd., Korea Lymphoma, Large-Cell, Diffuse|Lymphoma, B-Cell September 2006 Phase 1|Phase 2
NCT00002878 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group|Cancer and Leukemia Group B|NCIC Clinical Trials Group|European Organisation for Research and Treatment of Cancer - EORTC Multiple Myeloma and Plasma Cell Neoplasm March 1997 Phase 3
NCT00054158 Roswell Park Cancer Institute|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm August 2004 Phase 2
NCT00085202 St. Jude Children's Research Hospital Brain and Central Nervous System Tumors August 2003 Phase 3
NCT01370694 Merck Sharp & Dohme Corp. Follicular Lymphoma August 19, 2011 Phase 1
NCT00002995 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma August 1997 Phase 3
NCT03225924 The Lymphoma Academic Research Organisation DLBCL July 2017 Phase 1|Phase 2
NCT00005796 Indiana University|Indiana University Melvin and Bren Simon Cancer Center Bone Marrow Suppression|Brain and Central Nervous System Tumors|Drug/Agent Toxicity by Tissue/Organ February 2000 Phase 1
NCT03188198 Mansoura University Large B Cell Lymphoma June 1, 2016 Phase 2
NCT02596971 Hoffmann-La Roche Diffuse Large B-Cell Lymphoma, Lymphoma Follicular December 22, 2015 Phase 1
NCT00184041 University of Southern California Acute Lymphoblastic Leukemia July 2004 Phase 2
NCT01831505 Presage Biosciences|National Institutes of Health (NIH)|National Cancer Institute (NCI)|Fred Hutchinson Cancer Research Center Lymphoma November 2012 Phase 1
NCT02427620 M.D. Anderson Cancer Center|Pharmacyclics LLC. Lymphoma June 2015 Phase 2
NCT02529852 M.D. Anderson Cancer Center|Celgene|Genentech, Inc. Lymphoma November 4, 2015 Phase 1|Phase 2
NCT00651755 M.D. Anderson Cancer Center|Merck Sharp & Dohme Corp. Lymphoma March 2008
NCT00960063 Merck Sharp & Dohme Corp. Neoplasms|Solid Tumors|Bone Cancer|Kidney Tumor|Neuroblastoma November 11, 2009 Phase 1
NCT00882206 Masonic Cancer Center, University of Minnesota Leukemia|Lymphoma April 2009 Phase 2
NCT02724579 Children's Oncology Group|National Cancer Institute (NCI) Untreated Childhood Medulloblastoma October 2016 Phase 2
NCT02684708 Prof. Dr. Christine Mauz-Körholz|Deutsche Krebshilfe e.V., Bonn (Germany)|Euronet Worldwide|University of Giessen Classical Hodgkin Lymphoma October 2015 Phase 3
NCT00302003 Children's Oncology Group|National Cancer Institute (NCI) Childhood Favorable Prognosis Hodgkin Lymphoma|Childhood Lymphocyte Depletion Hodgkin Lymphoma|Childhood Mixed Cellularity Hodgkin Lymphoma|Childhood Nodular Sclerosis Hodgkin Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage II Childhood Hodgkin Lymphoma February 2006 Phase 3
NCT00003859 Societe Internationale d'Oncologie Pediatrique|National Cancer Institute (NCI) Brain and Central Nervous System Tumors April 1992 Phase 3
NCT02293109 University of California, Davis|Amgen Contiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia December 2015 Phase 1
NCT00618813 Children's Oncology Group|National Cancer Institute (NCI) Ewing Sarcoma of Bone|Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor March 2008
NCT00433537 National Cancer Institute (NCI) Contiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Stage I Mantle Cell Lymphoma|Stage III Mantle Cell Lymphoma|Stage IV Mantle Cell Lymphoma May 2007 Phase 2
NCT02285062 Celgene Lymphoma, Large B-Cell, Diffuse January 21, 2015 Phase 3
NCT00107198 Children's Oncology Group|National Cancer Institute (NCI) Childhood Lymphocyte Predominant Hodgkin Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage II Childhood Hodgkin Lymphoma January 2006
NCT00186888 St. Jude Children's Research Hospital|National Cancer Institute (NCI) Retinoblastoma|Retinal Neoplasm February 2005 Phase 3
NCT01414855 Genentech, Inc. Lymphoma, B-Cell August 31, 2011 Phase 2
NCT00581776 University of Wisconsin, Madison Mantle Cell Lymphoma May 2005 Phase 2
NCT00002556 National Cancer Institute (NCI) Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma July 1994 Phase 3
NCT02626455 Bayer Lymphoma, Non-Hodgkin January 6, 2016 Phase 3
NCT00022178 The Christie NHS Foundation Trust|National Cancer Institute (NCI) Carcinoma of Unknown Primary December 1998 Phase 3
NCT01321008 M.D. Anderson Cancer Center Lymphoma May 2011 Phase 1|Phase 2
NCT00389818 AIDS Malignancy Consortium|National Cancer Institute (NCI)|The EMMES Corporation Lymphoma January 2007 Phase 2
NCT00003667 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Sarcoma September 1998 Phase 2
NCT02343536 Celgene Lymphoma, Large B-Cell, Diffuse|Lymphoma, Follicular April 29, 2015 Phase 1
NCT00002466 Memorial Sloan Kettering Cancer Center Kidney Cancer|Sarcoma May 1990 Phase 2
NCT01606878 Children's Oncology Group|National Cancer Institute (NCI) Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Neuroblastoma|Unspecified Childhood Solid Tumor, Protocol Specific March 2013 Phase 1
NCT01334502 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma March 2012 Phase 1
NCT00549848 St. Jude Children's Research Hospital|National Cancer Institute (NCI)|Enzon Pharmaceuticals, Inc.|National Institute of General Medical Sciences (NIGMS) Acute Lymphoblastic Leukemia October 29, 2007 Phase 3
NCT00002822 Medical Research Council|National Cancer Institute (NCI) Lung Cancer March 1996 Phase 3
NCT00054665 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) B-Cell Lymphoma February 2003 Phase 2
NCT01539174 Fox Chase Cancer Center|Genentech, Inc. Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma Phase 2
NCT00088530 CTI BioPharma Lymphoma, Non-Hodgkin July 2004 Phase 3
NCT00335140 Eastern Cooperative Oncology Group Lymphoma December 2006 Phase 2
NCT00088881 National Cancer Institute (NCI) Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Splenic Marginal Zone Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Testicular Lymphoma|Waldenström Macroglobulinemia December 2004 Phase 2
NCT02703272 Janssen Research & Development, LLC Lymphoma, Non-Hodgkin July 1, 2016 Phase 3
NCT02333513 Hebei Yanda Hospital|Beijing Tiantan Hospital Recurrent High-grade Glioma February 2015
NCT00003211 St. Jude Children's Research Hospital|National Cancer Institute (NCI) Brain and Central Nervous System Tumors October 1996 Phase 2
NCT00392327 Children's Oncology Group|National Cancer Institute (NCI) Untreated Childhood Medulloblastoma|Untreated Childhood Pineoblastoma|Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor March 2007 Phase 3
NCT02776605 PETHEMA Foundation ALL June 2016 Phase 2
NCT02166463 National Cancer Institute (NCI) Classical Hodgkin Lymphoma|Stage IIB Hodgkin Lymphoma|Stage IIIB Hodgkin Lymphoma|Stage IVA Hodgkin Lymphoma|Stage IVB Hodgkin Lymphoma March 16, 2015 Phase 3
NCT01775475 AIDS Malignancy Consortium|National Cancer Institute (NCI)|The EMMES Corporation AIDS-related Diffuse Large Cell Lymphoma|AIDS-related Diffuse Mixed Cell Lymphoma|AIDS-related Diffuse Small Cleaved Cell Lymphoma|AIDS-related Immunoblastic Large Cell Lymphoma|AIDS-related Lymphoblastic Lymphoma|AIDS-related Peripheral/Systemic Lymphoma|AIDS-related Small Noncleaved Cell Lymphoma|Stage III AIDS-related Lymphoma|Stage IV AIDS-related Lymphoma September 2016 Phase 2
NCT02541565 University of Washington|National Cancer Institute (NCI) Composite Lymphoma|Grade 3b Follicular Lymphoma|Stage I Diffuse Large B-Cell Lymphoma|Stage I Follicular Lymphoma|Stage II Diffuse Large B-Cell Lymphoma|Stage II Follicular Lymphoma|Stage III Diffuse Large B-Cell Lymphoma|Stage III Follicular Lymphoma|Stage IV Diffuse Large B-Cell Lymphoma|Stage IV Follicular Lymphoma November 24, 2015 Phase 2
NCT02212574 Sidney Kimmel Comprehensive Cancer Center Medulloblastoma March 2015
NCT00972478 National Cancer Institute (NCI) Stage II Contiguous Adult Diffuse Large Cell Lymphoma|Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma November 2010 Phase 1|Phase 2
NCT00537550 Gruppo Italiano Malattie EMatologiche dell'Adulto Leukemia, Lymphocytic, Acute July 2000
NCT02213913 University of Chicago|National Cancer Institute (NCI) Adult Grade III Lymphomatoid Granulomatosis|B-cell Chronic Lymphocytic Leukemia|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Conti July 2014 Phase 1|Phase 2
NCT02561273 University of Nebraska|National Cancer Institute (NCI) Anaplastic Large Cell Lymphoma, ALK-Negative|Anaplastic Large Cell Lymphoma, ALK-Positive|Hepatosplenic T-Cell Lymphoma|Peripheral T-Cell Lymphoma, Not Otherwise Specified|Stage II Angioimmunoblastic T-cell Lymphoma|Stage II Enteropathy-Associated T-Cell Lymphoma|Stage III Angioimmunoblastic T-cell Lymphoma|Stage III Enteropathy-Associated T-Cell Lymphoma|Stage IV Angioimmunoblastic T-cell Lymphoma|Stage IV Enteropathy-Associated T-Cell Lymphoma October 2015 Phase 1|Phase 2
NCT01746992 Ruijin Hospital ALK-negative Anaplastic Large Cell Lymphoma|Peripherial T Cell Lymphoma,Not Otherwise Specified|Angioimmunoblastic T Cell Lymphoma|Enteropathy Associated T Cell Lymphoma|Hepatosplenic T Cell Lymphoma|Subcutaneous Panniculitis Like T Cell Lymphoma September 2012 Phase 4
NCT01096368 Children's Oncology Group|National Cancer Institute (NCI) Childhood Infratentorial Ependymoma|Childhood Supratentorial Ependymoma|Newly Diagnosed Childhood Ependymoma March 2010 Phase 3
NCT00841945 French Innovative Leukemia Organisation B Cell Lymphoma April 2005 Phase 3
NCT01871766 St. Jude Children's Research Hospital Rhabdomyosarcoma December 4, 2013 Phase 2
NCT00201318 National Health Research Institutes, Taiwan|National Taiwan University Hospital|Mackay Memorial Hospital|National Cheng-Kung University Hospital|Taipei Veterans General Hospital, Taiwan|Chi Mei Medical Hospital Non-Hodgkin's Lymphoma September 2001 Phase 2
NCT01464606 Children's Hospitals and Clinics of Minnesota Pleuropulmonary Blastoma September 2011
NCT00513955 Plymouth Hospitals NHS Trust Lymphoma June 2006 Phase 2
NCT02306161 National Cancer Institute (NCI) Metastatic Ewing Sarcoma|Metastatic Malignant Neoplasm in the Bone|Metastatic Malignant Neoplasm in the Bone Marrow|Metastatic Malignant Neoplasm in the Lung|Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone|Peripheral Primitive Neuroectodermal Tumor of Soft Tissues December 8, 2014 Phase 3
NCT01014767 Tufts Medical Center Brain Cancer|Choroid Plexus Tumors November 2009 Phase 3
NCT00002908 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Leukemia|Lymphoma December 1996 Phase 2
NCT00846703 Sun Yat-sen University Acute Lymphoblastic Leukemia July 2008 Phase 4
NCT00450385 University of Miami Lymphoma April 24, 2007 Phase 2
NCT03117751 St. Jude Children's Research Hospital|Bristol-Myers Squibb|Incyte Corporation|Shire Acute Lymphoblastic Leukemia|Acute Lymphoblastic Lymphoma March 29, 2017 Phase 2|Phase 3
NCT00006184 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Multiple Myeloma August 2000 Phase 2
NCT01516567 Gustave Roussy, Cancer Campus, Grand Paris|Children's Oncology Group Primary Mediastinal Large B Cell Lymphoma December 2011 Phase 2
NCT01376427 PETHEMA Foundation Acute Lymphoblastic Leukemia Ph Positive January 2007
NCT02419469 M.D. Anderson Cancer Center|Jazz Pharmaceuticals Leukemia|Precursor-B Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|Lymphoma November 13, 2015 Phase 2
NCT00594815 Memorial Sloan Kettering Cancer Center|Northwestern Memorial Hospital|Columbia University|Kentuckiana Cancer Institute|University of Virginia|University of Vermont Lymphoma August 28, 2002
NCT00365274 National Cancer Institute (NCI) Anaplastic Large Cell Lymphoma August 2006 Phase 2
NCT01516580 Gustave Roussy, Cancer Campus, Grand Paris|Children's Oncology Group B-cell Non Hodgkin Lymphoma|Mature B-cell Leukemia Burkitt-type December 2011 Phase 3
NCT00187161 St. Jude Children's Research Hospital Non-Hodgkin Lymphoma|Acute Lymphoblastic Leukemia, Mature B-Cell November 1994 Phase 2
NCT01679119 University College, London|Pfizer|Cancer Research UK Diffuse Large B Cell Lymphoma October 2013 Phase 2
NCT00000801 National Institute of Allergy and Infectious Diseases (NIAID) Lymphoma, Non-Hodgkin|HIV Infections Phase 2
NCT00825149 Hoffmann-La Roche Non-Hodgkin's Lymphoma February 2009 Phase 1
NCT02877303 M.D. Anderson Cancer Center|Amgen Leukemia|Acute Lymphoblastic Leukemia November 2016 Phase 2
NCT00002944 Children's Oncology Group|National Cancer Institute (NCI) Brain Tumors|Central Nervous System Tumors April 1997 Phase 3
NCT00060346 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lymphoma June 2004 Phase 2
NCT00801281 Polish Lymphoma Research Group Follicular Lymphoma|Marginal Zone Lymphoma|Small Lymphocytic Lymphoma|Lymphoplasmacytic Lymphoma February 2007 Phase 3
NCT00945724 International Extranodal Lymphoma Study Group (IELSG) Large B-cell Diffuse Lymphoma of Testis April 2009 Phase 2
NCT00719472 Genentech, Inc. Non-Hodgkin's Lymphoma July 2008 Phase 3
NCT00115700 Trans-Tasman Radiation Oncology Group (TROG)|Australasian Leukaemia and Lymphoma Group Follicular Lymphoma February 2000 Phase 3
NCT00866749 M.D. Anderson Cancer Center Lymphoblastic Leukemia|Lymphoblastic Lymphoma September 2006 Phase 2
NCT00003994 Children's Oncology Group|National Cancer Institute (NCI) Childhood Hepatoblastoma|Recurrent Childhood Liver Cancer|Stage I Childhood Liver Cancer March 1999 Phase 3
NCT00053768 German High-Grade Non-Hodgkin's Lymphoma Study Group|National Cancer Institute (NCI) Lymphoma April 2002 Phase 3
NCT01483690 Therapeutic Advances in Childhood Leukemia Consortium Acute Lymphoblastic Leukemia|Precursor B-Cell Lymphoblastic Leukemia|Precursor T-Cell Lymphoblastic Leukemia December 2011 Phase 1|Phase 2
NCT00043979 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Sarcoma September 19, 2002 Phase 2
NCT00002569 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|North Central Cancer Treatment Group|Southwest Oncology Group|Eastern Cooperative Oncology Group|NCIC Clinical Trials Group Brain and Central Nervous System Tumors July 1994 Phase 3
NCT00005867 Lymphoma Trials Office|National Cancer Institute (NCI) Lymphoma January 1998 Phase 3
NCT00333008 The Alvin and Lois Lapidus Cancer Institute|Ortho Biotech Products, L.P. Diffuse Large B Cell Lymphoma|Lymphoma, Non-Hodgkin May 2006 Phase 2
NCT02858804 Institute of Hematology & Blood Diseases Hospital Mantle Cell Lymphoma January 2016 Phase 4
NCT00301782 Medical Research Council|National Cancer Institute (NCI) Extragonadal Germ Cell Tumor|Teratoma|Testicular Germ Cell Tumor June 2005 Phase 2
NCT01287741 Hoffmann-La Roche|Fondazione Italiana Linfomi ONLUS Diffuse Large B-Cell Lymphoma July 2011 Phase 3
NCT00290498 M.D. Anderson Cancer Center|Genentech, Inc. Lymphoma August 2005 Phase 2
NCT00736320 University of Cologne Hodgkin Lymphoma November 2009 Phase 3
NCT00390793 M.D. Anderson Cancer Center|Bristol-Myers Squibb Acute Lymphoblastic Leukemia|Leukemia September 2006 Phase 2
NCT02617485 Mabion SA Diffuse Large B-Cell Lymphoma December 2015 Phase 3
NCT00690560 Centre Antoine Lacassagne Lymphoma May 2007 Phase 2
NCT02398240 Mitchell Cairo|New York Medical College Hodgkin Lymphoma May 2015 Phase 2
NCT00217425 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lymphoma July 2006 Phase 2
NCT00006461 Children's Oncology Group|National Cancer Institute (NCI) Untreated Childhood Medulloblastoma|Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor October 2000 Phase 3
NCT02420717 M.D. Anderson Cancer Center|Incyte Corporation Leukemia July 2015 Phase 2
NCT02809573 Chipscreen Biosciences, Ltd. Peripheral T-cell Lymphoma August 11, 2016 Phase 1
NCT00707083 Prince of Wales Hospital, Shatin, Hong Kong Leukemia May 2008 Phase 3
NCT00002576 Cancer Research Campaign Clinical Trials Centre|National Cancer Institute (NCI) Lymphoma November 1992 Phase 3
NCT00002875 Children's Oncology Group|National Cancer Institute (NCI)|Pediatric Oncology Group Brain Tumors|Central Nervous System Tumors December 1996 Phase 3
NCT01468740 Harlachinger Krebshilfe e.V.|Deutsche AIDS Gesellschaft e.V. HIV-associated Hodgkin Lymphoma March 2004 Phase 2
NCT00085735 Children's Oncology Group|National Cancer Institute (NCI) Untreated Childhood Medulloblastoma April 2004 Phase 3
NCT00285389 French Innovative Leukemia Organisation|Hoffmann-La Roche Mantle Cell Lymphoma February 2002 Phase 2
NCT00003375 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group|North Central Cancer Treatment Group|Eastern Cooperative Oncology Group|NRG Oncology Brain and Central Nervous System Tumors October 1998 Phase 2|Phase 3
NCT01670084 Mayo Clinic B-cell Adult Acute Lymphoblastic Leukemia|Blastic Phase Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia December 2012 Phase 2
NCT00003804 University of Leicester|National Cancer Institute (NCI) Kidney Cancer July 1993 Phase 3
NCT00101101 H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|Lymphoma Research Foundation|Novartis Lymphoma July 2004 Phase 2
NCT00209222 European Mantle Cell Lymphoma Network|German Low Grade Lymphoma Study Group|Lymphoma Study Association Lymphoma, Mantle-Cell July 2004 Phase 3
NCT00360750 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Retinoblastoma September 2005
NCT00416676 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Neuroblastoma Phase 3
NCT01704716 St. Anna Kinderkrebsforschung Neuroblastoma February 2002 Phase 3
NCT00290433 M.D. Anderson Cancer Center|Ortho Biotech, Inc. Lymphoma September 2003 Phase 2
NCT01622439 Lund University Hospital|Valcuria Diffuse Large B-cell Lymphoma June 2012 Phase 1|Phase 2
NCT03023358 Nanfang Hospital of Southern Medical University Peripheral T Cell Lymphoma February 2017 Phase 3
NCT01451515 St. Jude Children's Research Hospital|National University, Singapore Lymphoblastic Lymphoma May 25, 2012 Phase 2
NCT00003204 National Cancer Institute (NCI) Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Small Lymphocytic Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Small Lymphocytic Lymphoma March 1998 Phase 3
NCT01004497 The Catholic University of Korea Acute Lymphoblastic Leukemia March 2010 Phase 2
NCT02449278 Wuhan University Diffuse Large B-cell Lymphoma October 2015 Phase 3
NCT02449265 Wuhan University Diffuse Large B-cell Lymphoma October 2015 Phase 3
NCT00169156 Lymphoma Study Association|Hoffmann-La Roche Untreated T-cell Angioimmunoblastic Lymphoma December 2005 Phase 2
NCT00477412 M.D. Anderson Cancer Center|Millennium Pharmaceuticals, Inc. Mantle Cell Lymphoma|Lymphoma April 2007 Phase 1
NCT00931918 Millennium Pharmaceuticals, Inc.|Takeda Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL) October 2009 Phase 2
NCT02660762 Sun Yat-sen University Leukaemia,Lymphoblastic January 2016 Phase 2
NCT00501826 M.D. Anderson Cancer Center|Novartis Leukemia|Lymphoblastic Lymphoma|Leukemia, Lymphoblastic, Acute July 11, 2007 Phase 2
NCT02828358 National Cancer Institute (NCI) Acute Leukemia of Ambiguous Lineage|Childhood B Acute Lymphoblastic Leukemia|KMT2A Gene Rearrangement|Mixed Phenotype Acute Leukemia March 27, 2017 Phase 2
NCT02752815 Ruijin Hospital Diffuse Large B-cell Lymphoma April 2016 Phase 4
NCT00928200 Therapeutic Advances in Childhood Leukemia Consortium Relapsed Acute Lymphoblastic Leukemia|Allergy to PEG e.Coli Asparaginase|Allergy to Native e.Coli Asparaginase May 2009 Phase 1
NCT00267046 M.D. Anderson Cancer Center Sarcoma|Oral Mucositis December 2005 Phase 2
NCT00890656 M.D. Anderson Cancer Center|Enzon Pharmaceuticals, Inc. Acute Lymphoblastic Leukemia June 2003 Phase 2
NCT01424982 M.D. Anderson Cancer Center|Ariad Pharmaceuticals Leukemia October 2011 Phase 2
NCT00301821 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma January 2006 Phase 2
NCT00866307 Children's Oncology Group|National Cancer Institute (NCI) B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia February 2009
NCT00225173 Stanford University|National Cancer Institute (NCI) Hodgkin Disease October 2001 Phase 2
NCT00209209 European Mantle Cell Lymphoma Network|German Low Grade Lymphoma Study Group|Lymphoma Study Association|HOVON - Dutch Haemato-Oncology Association|Nordic Lymphoma Group Lymphoma, Mantle-Cell January 14, 2004 Phase 3
NCT00867178 National Cancer Institute (NCI) Untreated Childhood Medulloblastoma|Untreated Childhood Pineoblastoma|Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor February 25, 2009
NCT00973752 Massachusetts General Hospital|Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Enzon Pharmaceuticals, Inc.|Genzyme, a Sanofi Company Acute Lymphoblastic Leukemia August 2009 Phase 2
NCT00186875 St. Jude Children's Research Hospital Acute Lymphoblastic Leukemia|Lymphoma, Lymphoblastic November 2003 Phase 2
NCT01523977 Dana-Farber Cancer Institute|Novartis Acute Lymphoblastic Leukemia November 2011 Phase 1
NCT00031590 Children's Hospital of Philadelphia Brain Tumors|Central Nervous System Tumors|Medulloblastoma|Primitive Neuroectodermal Tumor April 2001 Phase 2
NCT01889069 Hoffmann-La Roche Lymphoma July 31, 2013 Phase 3
NCT00006721 Southwest Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group Lymphoma March 2001 Phase 3
NCT00000689 National Institute of Allergy and Infectious Diseases (NIAID) Lymphoma, Non-Hodgkin|HIV Infections Phase 1
NCT01946529 St. Jude Children's Research Hospital|University of Tennessee Health Science Center|University of Florida|Nemours Children's Clinic Desmoplastic Small Round Cell Tumor|Ewing Sarcoma of Bone or Soft Tissue|Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor November 2013 Phase 2
NCT01700946 St. Jude Children's Research Hospital|Cookies for Kids' Cancer|Assisi Foundation Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood B-Lymphoblastic Lymphoma April 15, 2013 Phase 2
NCT02797717 GALIA AVRAHAMI|University of Giessen|Rabin Medical Center Classical Hodgkins Lymphoma in Children and Adolescents. November 2015
NCT00187005 St. Jude Children's Research Hospital Acute Lymphoblastic Leukemia July 1998 Phase 3
NCT01303887 University of Liverpool|Royal Liverpool and Broadgreen University Hospitals NHS Trust|Cancer Research UK|Roche Pharma AG Follicular Lymphoma October 2009 Phase 3
NCT00290667 German High-Grade Non-Hodgkin's Lymphoma Study Group Lymphoma February 2004 Phase 2
NCT01055314 National Cancer Institute (NCI) Adult Rhabdomyosarcoma|Childhood Alveolar Rhabdomyosarcoma|Childhood Embryonal Rhabdomyosarcoma|Metastatic Childhood Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma|Untreated Childhood Rhabdomyosarcoma January 2010 Phase 2
NCT00195871 Centre Henri Becquerel Lymphoblastic Lymphoma February 2004 Phase 2
NCT00363090 Toronto Sunnybrook Regional Cancer Centre|National Cancer Institute (NCI) Lymphoma September 2006 Phase 1|Phase 2
NCT02406092 Hoffmann-La Roche Non-Hodgkin Lymphoma October 13, 2015 Phase 3
NCT00022945 Corixa Corporation Mantle Cell Lymphoma Phase 2
NCT00734773 Northwestern University|Pharmacyclics LLC. Brain and Central Nervous System Tumors|Lymphoma|Neurotoxicity November 2008 Early Phase 1
NCT00896519 French Innovative Leukemia Organisation|National Cancer Institute (NCI) Lymphoma March 2009 Phase 2
NCT00061893 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma April 2004 Phase 2
NCT00041132 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma September 2002 Phase 2
NCT01359592 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma September 2011 Phase 2
NCT02553460 St. Jude Children's Research Hospital|Gateway for Cancer Research|Texas Children's Hospital Acute Lymphoblastic Leukemia January 29, 2016 Phase 1|Phase 2
NCT00324831 Favrille|National Cancer Institute (NCI) Lymphoma Phase 3
NCT02114229 St. Jude Children's Research Hospital|Millennium Pharmaceuticals, Inc. Malignant Rhabdoid Tumor|Atypical Teratoid Rhabdoid Tumor May 14, 2014 Phase 2
NCT02870907 Institut Curie Retinoblastoma March 2010 Phase 2
NCT00002816 Children's Oncology Group|National Cancer Institute (NCI) Leukemia December 1996 Phase 3
NCT01864109 Memorial Sloan Kettering Cancer Center Newly Diagnosed Ewing Sarcoma May 2013 Phase 2
NCT02073097 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma October 2014 Phase 1|Phase 2
NCT00038610 M.D. Anderson Cancer Center|Novartis Pharmaceuticals Leukemia March 2001 Phase 2
NCT02228512 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease|Primary Effusion Lymphoma August 15, 2014 Phase 1|Phase 2
NCT00000658 National Institute of Allergy and Infectious Diseases (NIAID)|Schering-Plough Lymphoma, Non-Hodgkin|HIV Infections Phase 3
NCT02531308 Rush University Medical Center Diffuse Large B-Cell Lymphoma July 2015 Phase 2
NCT01746173 Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center T-cell Non-Hodgkin Lymphoma February 2013 Phase 2
NCT00136084 St. Jude Children's Research Hospital|National Cancer Institute (NCI) Leukemia, Myelocytic, Acute August 2002 Phase 3
NCT01540812 PETHEMA Foundation Acute Lymphoblastic Leukemia February 2012 Phase 4
NCT00968253 M.D. Anderson Cancer Center|Novartis Leukemia|Acute Lymphocytic Leukemia November 2009 Phase 1|Phase 2
NCT00003573 Children's Oncology Group|National Cancer Institute (NCI) Brain Tumors|Central Nervous System Tumors November 1998 Phase 2
NCT01769209 Stanford University|National Cancer Institute (NCI) B-cell Adult Acute Lymphoblastic Leukemia|Ph Positive Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|T-cell Adult Acute Lymphoblastic Leukemia March 2013 Phase 2
NCT02753647 Ruijin Hospital Diffuse Large B-cell Lymphoma April 2016 Phase 2
NCT00098839 Children's Oncology Group|National Cancer Institute (NCI) Recurrent Childhood Acute Lymphoblastic Leukemia February 2005 Phase 1|Phase 2
NCT01857934 St. Jude Children's Research Hospital|Cookies for Kids' Cancer|CURE Childhood Cancer, Inc. Neuroblastoma July 5, 2013 Phase 2
NCT02449252 Wuhan University Follicular Lymphoma October 2015 Phase 3
NCT01000285 Washington University School of Medicine Leukemia-Lymphoma, Adult T-Cell September 2010 Phase 1|Phase 2
NCT01777152 Seattle Genetics, Inc.|Millennium Pharmaceuticals, Inc. Anaplastic Large-Cell Lymphoma|Non-Hodgkin Lymphoma|T-Cell Lymphoma January 2013 Phase 3
NCT00006734 Children's Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group Sarcoma May 2001 Phase 3
NCT01005914 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Leukemia June 2009 Phase 2
NCT00084838 Dana-Farber Cancer Institute|National Cancer Institute (NCI) Central Nervous System Tumor, Pediatric February 2003 Phase 2
NCT00336024 Children's Oncology Group|National Cancer Institute (NCI) Untreated Childhood Medulloblastoma|Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor August 2007 Phase 3
NCT00096135 Children's Oncology Group|National Cancer Institute (NCI) Leukemia November 2004
NCT03036904 Weill Medical College of Cornell University|Genentech, Inc.|Massachusetts General Hospital|M.D. Anderson Cancer Center Diffuse Large B-Cell Lymphoma|High Grade B-Cell Lymphoma February 6, 2017 Phase 1
NCT02337985 City of Hope Medical Center|National Cancer Institute (NCI) AIDS-Related Burkitt Lymphoma|AIDS-Related Diffuse Large B-cell Lymphoma|AIDS-Related Plasmablastic Lymphoma|AIDS-Related Primary Effusion Lymphoma|HIV Infection|AIDS Related Non-Hodgkin Lymphoma August 3, 2015
NCT01193842 National Cancer Institute (NCI) AIDS-Related Diffuse Large Cell Lymphoma|AIDS-Related Plasmablastic Lymphoma|AIDS-Related Primary Effusion Lymphoma|Grade 3b Follicular Lymphoma|HIV Infection|Plasmablastic Lymphoma|Primary Effusion Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage II Contiguous Adult Diffuse Large Cell Lymphoma|Stage II Grade 3 Contiguous Follicular Lymphoma|Stage II Grade 3 Non-Contiguou October 6, 2010 Phase 1|Phase 2
NCT01251107 Fondazione Michelangelo Hodgkin Lymphoma March 2000 Phase 3
NCT01435018 AIDS Clinical Trials Group|National Institute of Allergy and Infectious Diseases (NIAID)|National Cancer Institute (NCI)|National Institute of Dental and Craniofacial Research (NIDCR) HIV-1 Infection August 2013 Phase 3
NCT00274924 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lymphoma April 2006 Phase 2
NCT00002827 Children's Oncology Group|National Cancer Institute (NCI)|Children's Cancer Group Cardiac Toxicity|Lymphoma October 1996 Phase 3
NCT00005089 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma April 2000 Phase 2
NCT02303821 Amgen|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) - Study Design & Execution Collaborator|Innovative Therapies For Children with Cancer Consortium Acute Lymphoblastic Leukemia (ALL) December 2014 Phase 1
NCT00554788 Children's Oncology Group|National Cancer Institute (NCI) Extraocular Retinoblastoma February 2008 Phase 3
NCT02639650 Weiguo Lv|First Affiliated Hospital of Zhongshan Medical University|Shandong University|Huazhong University of Science and Technology|Women's Hospital School Of Medicine Zhejiang University Gestational Trophoblastic Neoplasms March 2016 Phase 3
NCT00005578 Children's Oncology Group|National Cancer Institute (NCI) Cardiac Toxicity|Lymphoma March 1997 Phase 3
NCT00176462 Rutgers, The State University of New Jersey|National Cancer Institute (NCI) Acute Lymphocytic Leukemia February 2001 Phase 2
NCT02405676 Children's Cancer Group, China|Tongji Hospital|Nanjing Children's Hospital|West China Second University Hospital|Xiangya Hospital of Central South University|Qilu Hospital of Shandong University|Children’s Hospital of Sochow University, China|Tianjin Medical University Cancer Institute and Hospital Mature B-cell Non-Hodgkin Lymphoma January 2015 Phase 2|Phase 3
NCT02732015 M.D. Anderson Cancer Center|Tesaro, Inc. Sarcoma October 2016 Phase 2
NCT01848132 Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea|Janssen-Cilag, S.A. Diffuse, Large B-Cell, Lymphoma October 3, 2013 Phase 2
NCT00410488 M.D. Anderson Cancer Center|Eisai Inc. Sarcoma|Nausea|Vomiting December 2006
NCT00278278 Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) Brain and Central Nervous System Tumors September 2003 Phase 3
NCT00004188 Children's Oncology Group|National Cancer Institute (NCI) Neuroblastoma February 2001 Phase 3
NCT01798004 Children's Oncology Group|National Cancer Institute (NCI) Disseminated Neuroblastoma|Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Regional Neuroblastoma|Stage 4S Neuroblastoma April 2013
NCT00126191 Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital Burkitt Lymphoma|Non-Hodgkins Lymphoma|Atypical Burkitt Lymphoma July 2005 Phase 2
NCT02767674 The First Affiliated Hospital with Nanjing Medical University Diffuse Large B Cell Lymphoma May 2016 Phase 3
NCT02228772 Massachusetts General Hospital|Millennium Pharmaceuticals, Inc. Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|B-cell Adult Acute Lymphoblastic Leukemia|T-cell Adult Acute Lymphoblastic Leukemia December 2014 Phase 1
NCT00039195 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Bristol-Myers Squibb|Genentech, Inc. Lymphoma November 2006 Phase 2
NCT00004031 Southwest Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|NCIC Clinical Trials Group Lymphoma July 1997 Phase 3
NCT00003141 Children's Oncology Group|National Cancer Institute (NCI) Brain Tumors|Central Nervous System Tumors|Neuroblastoma|Sarcoma March 1998 Phase 1
NCT02670616 Samsung Medical Center Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma May 2016 Phase 2
NCT01225874 Children's Oncology Group|National Cancer Institute (NCI) Leukemia December 1999
NCT02951728 Ruijin Hospital Diffuse Large B Cell Lymphoma October 2016 Phase 1|Phase 2
NCT00392886 Children's Hospital Los Angeles|National Cancer Institute (NCI) Brain and Central Nervous System Tumors March 2004 Phase 3
NCT00109837 Southwest Oncology Group|National Cancer Institute (NCI) Leukemia April 2005 Phase 2
NCT00967057 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Leukemia October 2002 Phase 3
NCT00004162 University of Alabama at Birmingham|National Cancer Institute (NCI) Lymphoma June 1997 Phase 1
NCT01878617 St. Jude Children's Research Hospital|Genentech, Inc.|National Cancer Institute (NCI) Medulloblastoma June 23, 2013 Phase 2
NCT00352027 St. Jude Children's Research Hospital Hodgkin's Lymphoma July 2006 Phase 2
NCT00005964 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma May 2000 Phase 2
NCT00983944 Kristie Blum|Ohio State University Comprehensive Cancer Center Lymphoma September 2009 Phase 2
NCT00002565 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Lymphoma May 1994 Phase 3
NCT03018626 Nanfang Hospital of Southern Medical University Lymphoma, Large B-Cell, Diffuse February 2017 Phase 3
NCT00039130 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Leukemia|Lymphoma May 2002 Phase 2
NCT02481310 Northwestern University|National Cancer Institute (NCI)|Millennium Pharmaceuticals, Inc. Adult Burkitt Lymphoma|B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma|Diffuse Large B-Cell Lymphoma|MYC Gene Mutation|Plasmablastic Lymphoma September 2015 Phase 1|Phase 2
NCT00577993 M.D. Anderson Cancer Center|Genentech, Inc. Lymphoma March 1998 Phase 3
NCT00846430 Spectrum Health Hospitals Neurofibromatosis 1 October 2008 Phase 2
NCT00101010 M.D. Anderson Cancer Center|National Cancer Institute (NCI)|Ortho Biotech, Inc. Lymphoma September 2005 Phase 2
NCT01358253 Ruijin Hospital Acute Lymphoblastic Leukemia December 2010 Phase 4
NCT01332968 Hoffmann-La Roche|German Low Grade Lymphoma Study Group|Institute of Cancer Research, United Kingdom Non-Hodgkin's Lymphoma August 1, 2011 Phase 3
NCT00003595 National Cancer Institute (NCI) Lymphoma January 1999 Phase 3
NCT00666484 University College, London Lymphoma|Neurotoxicity March 2008 Phase 2
NCT00118209 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Large B Cell Lymphoma May 2005 Phase 3
NCT00002571 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma June 1994 Phase 2
NCT00562965 Pfizer|UCB Pharma Lymphoma, Follicular November 2007 Phase 3
NCT00027846 Children's Oncology Group|National Cancer Institute (NCI) Brain Tumor|Central Nervous System Tumor August 2003 Phase 2
NCT00039351 European Organisation for Research and Treatment of Cancer - EORTC Lymphoma March 2002 Phase 2
NCT02535806 Children's Mercy Hospital Kansas City|Millennium Pharmaceuticals, Inc. Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma July 2015 Phase 2
NCT00002812 Children's Oncology Group|National Cancer Institute (NCI) Leukemia September 1996 Phase 3
NCT00058422 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lymphoma February 2003 Phase 2
NCT00003389 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lymphoma April 1999 Phase 3
NCT01230983 Children's Oncology Group|National Cancer Institute (NCI) Cardiac Toxicity|Leukemia|Lymphoma June 1996 Phase 3
NCT01200758 Hoffmann-La Roche Non-Hodgkin's Lymphoma February 15, 2011 Phase 3
NCT02918747 Hunan Cancer Hospital Lymphoma September 2016 Phase 3
NCT02661503 University of Cologne Classical Hodgkin Lymphoma July 2016 Phase 3
NCT00002657 Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm May 1995 Phase 2
NCT01783535 St. Jude Children's Research Hospital Retinoblastoma June 19, 2013 Phase 2
NCT01148446 Fondazione Italiana Linfomi ONLUS Elderly Patients (>65 Years)|Diffuse Large B Cell Lymphoma (DLBCL) January 2003 Phase 3
NCT00072280 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma November 2004 Phase 2
NCT01358201 PETHEMA Foundation Acute Lymphoblastic Leukemia May 2010 Phase 4
NCT01595048 Children's Oncology Group|National Cancer Institute (NCI) Childhood B Acute Lymphoblastic Leukemia|Childhood Burkitt Leukemia|Childhood Diffuse Large Cell Lymphoma|Mediastinal (Thymic) Large B-Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma June 2012 Phase 2|Phase 3
NCT00012207 Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI) Leukemia|Lymphoma September 2000 Phase 1
NCT01760226 Baylor College of Medicine|National Cancer Institute (NCI)|Texas Children's Hospital Diffuse Large B Cell Lymphoma|Post Transplant Lymphoproliferative Disorder|Primary Mediastinal (Thymic) Large B-cell Lymphoma January 2013
NCT00053872 University of Leicester|National Cancer Institute (NCI) Brain and Central Nervous System Tumors February 2003 Phase 3
NCT01724021 Hoffmann-La Roche Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma December 2012 Phase 3
NCT02116959 University of California, San Francisco Advanced Intra-Ocular Retinoblastoma|Retinoblastoma April 2014
NCT01026220 Children's Oncology Group|National Cancer Institute (NCI) Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage IV Childhood Hodgkin Lymphoma December 2009 Phase 3
NCT00005585 Children's Oncology Group|National Cancer Institute (NCI) Leukemia April 2000 Phase 3
NCT00002803 Children's Hospital Medical Center, Cincinnati|National Cancer Institute (NCI) Neuroblastoma July 1995 Phase 2
NCT00031902 Lymphoma Trials Office|National Cancer Institute (NCI) Lymphoma October 2001 Phase 1
NCT00015860 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Leukemia May 2001 Phase 1|Phase 2
NCT00187070 St. Jude Children's Research Hospital Lymphoma, Large Cell|Lymphoma, Non-Hodgkin December 1997
NCT01412879 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma November 2011 Phase 2
NCT00392834 AIDS Malignancy Consortium|National Cancer Institute (NCI)|The EMMES Corporation Lymphoma September 2006 Phase 2
NCT00003311 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Lymphoma March 1999 Phase 2
NCT00873093 National Cancer Institute (NCI) B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Lymphoblastic Lymphoma|T-cell Adult Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia March 2009 Phase 2
NCT00980460 National Cancer Institute (NCI) PRETEXT Stage 1 Hepatoblastoma|PRETEXT Stage 2 Hepatoblastoma|PRETEXT Stage 3 Hepatoblastoma|PRETEXT Stage 4 Hepatoblastoma September 14, 2009 Phase 3
NCT00006232 West of Scotland Lymphoma Group|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm October 1996 Phase 3
NCT00335556 Children's Oncology Group|National Cancer Institute (NCI) Childhood Renal Cell Carcinoma|Clear Cell Renal Cell Carcinoma|Clear Cell Sarcoma of the Kidney|Papillary Renal Cell Carcinoma|Rhabdoid Tumor of the Kidney|Stage I Renal Cell Cancer|Stage I Renal Wilms Tumor|Stage II Renal Cell Cancer|Stage II Renal Wilms Tumor|Stage III Renal Cell Cancer|Stage III Renal Wilms Tumor|Stage IV Renal Cell Cancer|Stage IV Renal Wilms Tumor June 2006 Phase 2
NCT00002548 Southwest Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group Multiple Myeloma January 1994 Phase 3
NCT00299182 M.D. Anderson Cancer Center|Amgen Lymphoma March 2006 Phase 1|Phase 2
NCT00005596 Children's Oncology Group|National Cancer Institute (NCI) Leukemia April 2000 Phase 3
NCT03147612 M.D. Anderson Cancer Center|Ariad Pharmaceuticals Acute Lymphoblastic Leukemia August 2017 Phase 2
NCT00005977 Children's Oncology Group|National Cancer Institute (NCI) Leukemia|Lymphoma September 2000 Phase 3
NCT00822120 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma|Nonneoplastic Condition July 2009 Phase 2
NCT03020030 Dana-Farber Cancer Institute|Baxalta US Inc. Acute Lymphoblastic Leukemia, Pediatric January 2017 Phase 3
NCT01228331 Universitätsklinikum Hamburg-Eppendorf Leukemia October 2010 Phase 2|Phase 3
NCT00025259 Children's Oncology Group|National Cancer Institute (NCI) Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma|Childhood Mixed Cellularity Classical Hodgkin Lymphoma|Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma|Childhood Nodular Sclerosis Classical Hodgkin Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage II Childhood Hodgkin Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage IV Childhood Hodgkin Lymphoma September 2002 Phase 3
NCT00103285 Children's Oncology Group|National Cancer Institute (NCI) B-cell Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia April 2005 Phase 3
NCT01490060 M.D. Anderson Cancer Center|Merck Sharp & Dohme Corp. Sarcoma|Chemotherapy-induced Nausea and Vomiting|Effects of Chemotherapy|Adverse Effects of Medical Drugs May 2012
NCT00678327 Cancer Research UK|National Cancer Institute (NCI) Lymphoma August 2008 Phase 3
NCT00020566 University of Leicester|National Cancer Institute (NCI)|Children's Cancer and Leukaemia Group|Societe Francaise Oncologie Pediatrique|European Organisation for Research and Treatment of Cancer - EORTC|Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria|Swiss Group for Clinical Cancer Research|EBMT Solid Tumors Working Party|Children's Oncology Group Sarcoma February 2001 Phase 3
NCT00083551 University of Arkansas|Celgene Corporation Multiple Myeloma August 1998 Phase 3
NCT01190930 Children's Oncology Group|National Cancer Institute (NCI) Adult B Lymphoblastic Lymphoma|Childhood B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1|Childhood B Lymphoblastic Lymphoma|Down Syndrome|Stage I B Lymphoblastic Lymphoma|Stage II B Lymphoblastic Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia August 2010 Phase 3
NCT00689845 University Hospital Southampton NHS Foundation Trust|National Cancer Institute (NCI) Lymphoma June 2007
NCT00004228 Children's Oncology Group|National Cancer Institute (NCI) Lymphoma June 2000 Phase 3
NCT02845882 Children's Cancer Group, China|Shanghai Children's Medical Center|Tongji Hospital|West China Second University Hospital|Qilu Hospital of Shandong University|Tianjin Medical University Cancer Institute and Hospital|Children’s Hospital of Sochow University, China|Nanjing Children's Hospital|Xiangya Hospital of Central South University Lymphoblastic Lymphoma January 2016 Phase 2|Phase 3
NCT00075725 Children's Oncology Group|National Cancer Institute (NCI) Leukemia December 2003 Phase 3
NCT00016302 National Cancer Institute (NCI) T-cell Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia April 2001
NCT01356680 University of Cologne Hodgkin Lymphoma December 2011 Phase 3
NCT00004224 Societe Internationale d'Oncologie Pediatrique|Children's Cancer and Leukaemia Group|Italian Association for Pediatric Hematology Oncology|National Cancer Institute (NCI) Brain and Central Nervous System Tumors January 1999 Phase 2
NCT00408005 National Cancer Institute (NCI) Adult T Acute Lymphoblastic Leukemia|Childhood T Acute Lymphoblastic Leukemia|Stage II Adult T-Cell Leukemia/Lymphoma|Stage II Childhood Lymphoblastic Lymphoma|Stage II Contiguous Adult Lymphoblastic Lymphoma|Stage II Non-Contiguous Adult Lymphoblastic Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-Cell Leukemia/Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-Cell Leukemia/Lymphoma|Stage IV Childhood Lymphoblastic Lymp January 22, 2007 Phase 3
NCT00003846 Children's Oncology Group|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Neuroblastoma July 1999 Phase 2
NCT02883049 National Cancer Institute (NCI) B Acute Lymphoblastic Leukemia|Bone Necrosis|Central Nervous System Leukemia|Cognitive Side Effects of Cancer Therapy|Neurotoxicity Syndrome|Pain|Ph-Like Acute Lymphoblastic Leukemia|Testicular Leukemia|Therapy-Related Toxicity|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia February 27, 2012 Phase 3
NCT00000703 National Institute of Allergy and Infectious Diseases (NIAID) Lymphoma, Non-Hodgkin|HIV Infections
NCT01920737 Memorial Sloan Kettering Cancer Center|Baxalta US Inc.|Duke University|Weill Medical College of Cornell University|Lehigh Valley Health Network Leukemia August 2013 Phase 2
NCT01363128 M.D. Anderson Cancer Center|Novartis Pharmaceuticals Leukemia July 12, 2011 Phase 2
NCT02786719 Baylor College of Medicine|Texas Children's Hospital Neuroblastoma June 2016
NCT00055640 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lymphoma October 2002 Phase 2
NCT00324467 British Columbia Cancer Agency|Hoffmann-La Roche Lymphoma, Non-Hodgkin|Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma August 2006 Phase 2
NCT03206671 University Hospital Muenster|Deutsche Krebshilfe e.V., Bonn (Germany) Mature B-cell Non-Hodgkin Lymphoma July 2017 Phase 3
NCT00003309 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group Brain and Central Nervous System Tumors July 1998 Phase 2
NCT00187122 St. Jude Children's Research Hospital Lymphoblastic Lymphoma March 1993
NCT00945009 Children's Oncology Group|National Cancer Institute (NCI) Adult Renal Wilms Tumor|Beckwith-Wiedemann Syndrome|Childhood Renal Wilms Tumor|Diffuse Hyperplastic Perilobar Nephroblastomatosis|Hemihypertrophy|Stage I Renal Wilms Tumor|Stage II Renal Wilms Tumor|Stage III Renal Wilms Tumor|Stage IV Renal Wilms Tumor|Stage V Renal Wilms Tumor July 2009 Phase 3
NCT03017326 University of Birmingham|Fundació Institut Germans Trias i Pujol|University of Padua|University of Newcastle Upon-Tyne|University Hospital Munich|University Hospital, Bonn|University of Kiel|University Hospital Tuebingen|Medical University of Gdansk Hepatoblastoma|Carcinoma, Hepatocellular May 2017 Phase 3
NCT01186328 Therapeutic Advances in Childhood Leukemia Consortium|Enzon Pharmaceuticals, Inc. Lymphoblastic Leukemia, Acute|Lymphoblastic Leukemia, Acute, Childhood|Leukemia, Lymphoblastic, Acute, T Cell|Leukemia, Lymphoblastic, Acute August 2010 Phase 1
NCT00002611 Children's Oncology Group|National Cancer Institute (NCI) Kidney Cancer July 1995 Phase 3
NCT00887146 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|European Organisation for Research and Treatment Center (EORTC)|NCIC Clinical Trials Group Brain and Central Nervous System Tumors September 2009 Phase 3
NCT00025610 European Infant Neuroblastoma Study Group - 1999|National Cancer Institute (NCI) Neuroblastoma July 1999 Phase 2
NCT00058370 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Brain and Central Nervous System Tumors February 2003
NCT00041327 AIDS Malignancy Consortium|National Cancer Institute (NCI) Lymphoma October 2002 Phase 2
NCT00002590 Children's Oncology Group|National Cancer Institute (NCI) Lymphoma July 1994 Phase 2
NCT00281905 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Neuroblastoma June 1992 Phase 2
NCT00567567 Children's Oncology Group|National Cancer Institute (NCI) Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Recurrent Neuroblastoma|Regional Neuroblastoma|Stage 4 Neuroblastoma|Stage 4S Neuroblastoma November 2007 Phase 3
NCT02881086 Johann Wolfgang Goethe University Hospital Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma August 2016 Phase 3
NCT00003543 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Colorectal Cancer June 1998 Phase 1
NCT00309881 German CLL Study Group Chronic Lymphocytic Leukemia April 2003 Phase 2
NCT00049036 National Cancer Institute (NCI) AIDS-related Diffuse Large Cell Lymphoma|AIDS-related Immunoblastic Large Cell Lymphoma|AIDS-related Peripheral/Systemic Lymphoma|AIDS-related Small Noncleaved Cell Lymphoma March 2003 Phase 2
NCT00379340 Children's Oncology Group|National Cancer Institute (NCI) Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q|Stage IV Wilms Tumor February 2007 Phase 3
NCT00853008 PETHEMA Foundation Acute Lymphoblastic Leukemia January 2003 Phase 4
NCT00736450 University of Nebraska|National Cancer Institute (NCI)|Genta Incorporated Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma July 2008
NCT00557193 Children's Oncology Group|National Cancer Institute (NCI) Acute Undifferentiated Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia January 2008 Phase 3
NCT00074490 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Lymphoma|Leukemia|Myeloproliferative Disorders|Multiple Myleoma|Myelodysplastic Syndrome December 11, 2003 Phase 2
NCT00072007 Swiss Group for Clinical Cancer Research Leukemia June 2002 Phase 2
NCT00039377 National Cancer Institute (NCI) Adult Acute Lymphoblastic Leukemia in Remission April 2002 Phase 2
NCT00002744 Children's Oncology Group|National Cancer Institute (NCI) Leukemia May 1996 Phase 3
NCT02911142 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Primary Effusion Lymphoma|B-Cell Lymphoma September 15, 2016 Phase 1|Phase 2
NCT01175356 Children's Oncology Group|National Cancer Institute (NCI) Disseminated Neuroblastoma|Ganglioneuroblastoma|Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Regional Neuroblastoma|Stage 4S Neuroblastoma October 2010
NCT00187057 St. Jude Children's Research Hospital|Children's Hospital of Philadelphia|National Cancer Institute (NCI) Ataxia-Telangiectasia September 2002
NCT00075699 Medical Research Council|National Cancer Institute (NCI) Malignant Mesothelioma September 2003 Phase 3
NCT00653068 Children's Oncology Group|National Cancer Institute (NCI) Childhood Atypical Teratoid/Rhabdoid Tumor December 2008 Phase 3
NCT00671034 Children's Oncology Group|National Cancer Institute (NCI) B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia July 2008
NCT00057811 Children's Oncology Group|National Cancer Institute (NCI) Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Childhood Small Noncleaved Cell Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Childhood Small Noncleaved Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Childhood Small Noncleaved Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Untreated Childhood Acute Lymphobla June 2004 Phase 2
NCT00022737 National Cancer Institute (NCI) Childhood Acute Lymphoblastic Leukemia in Remission|Recurrent Childhood Acute Lymphoblastic Leukemia October 2002 Phase 3
NCT00451178 Eli Lilly and Company Lymphoma May 2007 Phase 2
NCT00110006 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lymphoma December 2004
NCT00003955 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma September 1999 Phase 2
NCT00683319 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Brain and Central Nervous System Tumors|Cognitive/Functional Effects|Long-term Effects Secondary to Cancer Therapy in Children|Ototoxicity April 2008 Phase 3
NCT00287950 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Neuroblastoma September 1992
NCT00276731 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Neuroblastoma March 1995 Phase 3
NCT00006258 Children's Hospital Los Angeles|National Cancer Institute (NCI) Brain and Central Nervous System Tumors November 1997 Phase 2
NCT00002675 Memorial Sloan Kettering Cancer Center Retinoblastoma May 1995 Phase 2
NCT00003364 London Lung Cancer Group|National Cancer Institute (NCI) Lung Cancer January 1993 Phase 3
NCT00005945 Children's Oncology Group|National Cancer Institute (NCI) Leukemia June 2000 Phase 3
NCT00003783 Children's Oncology Group|National Cancer Institute (NCI) Leukemia March 1999 Phase 2
NCT00002618 Children's Oncology Group|National Cancer Institute (NCI) Lymphoma December 1994 Phase 3
NCT01004991 Weill Medical College of Cornell University|Celgene Diffuse Large B Cell Lymphoma January 2010 Phase 1|Phase 2
NCT02036489 PETHEMA Foundation Acute Lymphobkastic Leukemia January 2008 Phase 4
NCT00002740 Children's Oncology Group|National Cancer Institute (NCI) Neuroblastoma May 1996 Phase 1
NCT00003671 Children's Oncology Group|National Cancer Institute (NCI) Leukemia December 1998 Phase 2
NCT00003217 Children's Oncology Group|National Cancer Institute (NCI) Leukemia|Lymphoma March 1998 Phase 1
NCT00025623 European Infant Neuroblastoma Study Group - 1999|National Cancer Institute (NCI) Neuroblastoma July 1999 Phase 2
NCT00025597 European Infant Neuroblastoma Study Group - 1999|National Cancer Institute (NCI) Neuroblastoma July 1999 Phase 2
NCT00026208 Stanford University Lymphoma, Hodgkin Disease|Lymphoma|Hodgkin Disease|Lymphoma: Hodgkin June 2001 Phase 2
NCT00015873 Dutch Childhood Oncology Group Leukemia May 1999 Phase 3
NCT00005959 Amgen|National Cancer Institute (NCI) Lymphoma December 1999 Phase 2
NCT00004179 European Organisation for Research and Treatment of Cancer - EORTC|Lymphoma Trials Office|Stichting Hemato-Oncologie voor Volwassenen Nederland|Australasian Leukaemia and Lymphoma Group|NCIC Clinical Trials Group|Nordic Lymphoma Group Lymphoma May 1999 Phase 3
NCT00004112 University of Nebraska|National Cancer Institute (NCI) Lymphoma September 1999 Phase 3
NCT00284271 University of Cologne Hodgkin´s Lymphoma January 2004 Phase 2
NCT00003101 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Brain and Central Nervous System Tumors August 1997 Phase 2
NCT00002476 Cancer Research UK|National Cancer Institute (NCI) Head and Neck Cancer January 1990 Phase 3
NCT03126916 Children's Oncology Group|National Cancer Institute (NCI) Childhood Ganglioneuroblastoma|Childhood Neuroblastoma|NMYC Gene Amplification|Recurrent Neuroblastoma August 2017 Phase 3
NCT03007147 Children's Oncology Group|National Cancer Institute (NCI) B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|BCR-ABL1 Fusion Protein Expression|Minimal Residual Disease|Philadelphia Chromosome Positive|T Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia July 2017 Phase 3
NCT02112916 National Cancer Institute (NCI) Adult T Acute Lymphoblastic Leukemia|Childhood T Acute Lymphoblastic Leukemia|Stage II Childhood Lymphoblastic Lymphoma|Stage II Contiguous Adult Lymphoblastic Lymphoma|Stage II Non-Contiguous Adult Lymphoblastic Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia September 30, 2014 Phase 3
NCT02101853 National Cancer Institute (NCI) B Acute Lymphoblastic Leukemia December 8, 2014 Phase 3
NCT02003222 National Cancer Institute (NCI) B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative|BCR/ABL1 Fusion Protein Negative|Untreated Adult Acute Lymphoblastic Leukemia December 23, 2013 Phase 3
NCT01256398 National Cancer Institute (NCI) Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Untreated Adult Acute Lymphoblastic Leukemia December 14, 2010 Phase 2
NCT00792948 National Cancer Institute (NCI) Adult Acute Lymphoblastic Leukemia in Remission|Adult B Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Adult L1 Acute Lymphoblastic Leukemia|Adult L2 Acute Lymphoblastic Leukemia|Adult T Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia September 1, 2009 Phase 2
NCT00720109 National Cancer Institute (NCI) Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia July 2008 Phase 2|Phase 3
NCT00003152 European Organisation for Research and Treatment of Cancer - EORTC|Lymphoma Trials Office|Stichting Hemato-Oncologie voor Volwassenen Nederland Lymphoma March 1997 Phase 3
NCT00365755 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Neuroblastoma Phase 3
NCT00637832 University Hospital Southampton NHS Foundation Trust|National Cancer Institute (NCI) Lymphoma April 2008 Phase 2
NCT00003784 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma May 1999 Phase 2
NCT00028717 Commissie Voor Klinisch Toegepast Onderzoek|National Cancer Institute (NCI) Lymphoma February 2001 Phase 3
NCT00003150 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B|Southwest Oncology Group Lymphoma December 1997 Phase 3
NCT00376961 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma August 2006 Phase 2
NCT00017290 Genitope Corporation|National Cancer Institute (NCI) Lymphoma November 2000 Phase 3
NCT00004218 Leukemia Research Fund|Medical Research Council|National Cancer Institute (NCI) Leukemia October 1999 Phase 3
NCT00004039 Hoag Memorial Hospital Presbyterian|Cancer Biotherapy Research Group Lymphoma June 1998 Phase 2
NCT00187083 St. Jude Children's Research Hospital Acute Lymphoblastic Leukemia February 1997 Phase 3
NCT01415765 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Lymphoma, Diffuse Large-Cell B-cell|Diffuse, Large B-cell Lymphoma|Lymphoma, Diffuse Large-Cell|Large-Cell Lymphoma, Diffuse July 15, 2011 Phase 1|Phase 2
NCT00361621 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Millennium Pharmaceuticals, Inc. Non-Hodgkin's Lymphoma July 2006 Phase 2
NCT00137111 St. Jude Children's Research Hospital|National Cancer Institute (NCI) Lymphoblastic Leukemia, Acute June 2000 Phase 3
NCT00165139 Dana-Farber Cancer Institute|Boston Children’s Hospital|Children's Hospital of Philadelphia Neuroblastoma|Ewings Sarcoma|Non-rhabdomyosarcoma Soft Tissue Sarcoma January 1996 Phase 2
NCT00526305 PETHEMA Foundation Acute Lymphoblastic Leukemia January 2000 Phase 4
NCT00433459 Christine Mauz-Körholz|Deutsche Krebshilfe e.V., Bonn (Germany)|Euronet Worldwide|Martin-Luther-Universität Halle-Wittenberg Lymphoma January 2007 Phase 3
NCT00562068 Cancer Research UK|National Cancer Institute (NCI) Lymphoma|Small Intestine Cancer May 2007 Phase 1
NCT00662233 Mayo Clinic|National Cancer Institute (NCI) Ovarian Cancer|Sarcoma October 1991
NCT00025428 Societe Internationale d'Oncologie Pediatrique|Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Neuroblastoma December 2000 Phase 3
NCT00199186 Johann Wolfgang Goethe University Hospital Philadelphia Positive Acute Lymphoblastic Leukemia|Lymphoid Blastic Phase of Chronic Myeloid Leukemia March 2002 Phase 2
NCT00526175 PETHEMA Foundation Acute Lymphoblastic Leukemia June 2001 Phase 4
NCT00199069 Johann Wolfgang Goethe University Hospital|Deutsche Krebshilfe e.V., Bonn (Germany) Adult Acute Lymphocytic Leukemia April 1993 Phase 4
NCT00526409 PETHEMA Foundation Acute Lymphoblastic Leukemia June 2005 Phase 4
NCT00199017 Johann Wolfgang Goethe University Hospital Lymphoma, Lymphoblastic April 2004 Phase 4
NCT00199004 Johann Wolfgang Goethe University Hospital Adult Acute Lymphocytic Leukemia April 2004 Phase 4
NCT00198991 Johann Wolfgang Goethe University Hospital|Deutsche Krebshilfe e.V., Bonn (Germany)|German Federal Ministry of Education and Research Adult Acute Lymphocytic Leukemia April 2003 Phase 4
NCT00136435 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital|Queen Elizabeth II Health Sciences Centre Acute Lymphoblastic Leukemia June 2002 Phase 2
NCT00131027 Japan Adult Leukemia Study Group Lymphoblastic Leukemia, Acute September 2002 Phase 3
NCT00130195 Japan Adult Leukemia Study Group Acute Lymphoblastic Leukemia September 2002 Phase 2
NCT02894645 National University Hospital, Singapore Acute Lymphoblastic Leukemia (ALL) October 2008 Phase 4
NCT00556127 Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie Diffuse Large B-Cell Lymphoma|POOR PROGNOSIS June 2002 Phase 2
NCT00476190 Dana-Farber Cancer Institute|Massachusetts General Hospital|Boston Children’s Hospital|NCIC Clinical Trials Group Acute Lymphoblastic Leukemia April 2007 Phase 2
NCT00131053 Japan Adult Leukemia Study Group Lymphoblastic Leukemia, Acute September 2002 Phase 2
NCT00264953 University of Cologne Hodgkin´s Lymphoma May 1998 Phase 3
NCT00265031 University of Cologne Hodgkin´s Lymphoma January 1999 Phase 3
NCT02523976 Institute of Hematology & Blood Diseases Hospital Acute,Leukemia, Lymphoid August 2015 Phase 2
NCT00165178 Dana-Farber Cancer Institute|Boston Children’s Hospital|University of Rochester|McMaster University|San Jorge Children's Hospital (Puerto Rico)|St. Justine's Hospital|Maine Children's Cancer Program|Ochsner Health System|Tulane University School of Medicine|Laval University|Columbia University Acute Lymphoblastic Leukemia September 2000 Phase 3
NCT02611492 Assistance Publique - Hôpitaux de Paris Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia April 2016 Phase 3
NCT01309789 Seattle Genetics, Inc.|Millennium Pharmaceuticals, Inc. Lymphoma, Large-Cell, Anaplastic|Lymphoma, NK-cell|Lymphoma, T-cell February 2011 Phase 1
NCT00199095 Johann Wolfgang Goethe University Hospital Adult Acute Lymphocytic Leukemia February 1997 Phase 4
NCT01659099 The Lymphoma Academic Research Organisation|Hoffmann-La Roche Diffuse Large B Cell Lymphoma CD20 Positive September 2012 Phase 3
NCT00494897 PETHEMA Foundation Acute Lymphoblastic Leukemia June 1996 Phase 4
NCT00613457 Associazione Italiana Ematologia Oncologia Pediatrica Leukemia September 2000 Phase 3
NCT00440726 Therapeutic Advances in Childhood Leukemia Consortium Acute Lymphoblastic Leukemia June 2006 Phase 1|Phase 2
NCT00198978 Johann Wolfgang Goethe University Hospital Adult Acute Lymphocytic Leukemia January 2003 Phase 4
NCT00092222 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Lymphoproliferative Disorder|HHV-8|Malignancy|HIV September 17, 2004 Phase 2
NCT00049569 National Cancer Institute (NCI) L1 Childhood Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|Non-T, Non-B Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia January 2003
NCT00061945 National Cancer Institute (NCI) Acute Undifferentiated Leukemia|B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|L1 Adult Acute Lymphoblastic Leukemia|L1 Childhood Acute Lymphoblastic Leukemia|L2 Adult Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia|Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia|Philadelphia Chromosome Positive Childhood Precursor Acute Lymph June 2003 Phase 1|Phase 2
NCT03150693 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) B Acute Lymphoblastic Leukemia June 1, 2017 Phase 3
NCT00032149 Lymphoma Trials Office|National Cancer Institute (NCI) Lymphoma October 2001 Phase 1|Phase 2
NCT00416377 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Lymphoma
NCT00002987 Medical Research Council|National Cancer Institute (NCI) Lymphoma January 1997 Phase 3
NCT00398554 Christine Mauz-Körholz|Martin-Luther-Universität Halle-Wittenberg Lymphoma June 2005 Phase 2
NCT00047138 University of Leicester|Societe Francaise Oncologie Pediatrique|Children's Cancer and Leukaemia Group|Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) Kidney Cancer January 2001 Phase 3
NCT00379041 European Organisation for Research and Treatment of Cancer - EORTC Lymphoma September 1993 Phase 3
NCT00025064 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Lymphoma January 2000 Phase 2
NCT00003421 Medical Research Council|National Cancer Institute (NCI) Lymphoma June 1998 Phase 3
NCT00002898 Societe Internationale d'Oncologie Pediatrique|National Cancer Institute (NCI) Childhood Malignant Fibrous Histiocytoma of Bone|Sarcoma January 1995 Phase 3
NCT00002634 Memorial Sloan Kettering Cancer Center Neuroblastoma February 1995 Phase 2
NCT00002499 Grupo Argentino de Tratamiento de la Leucemia Aguda|National Cancer Institute (NCI) Leukemia January 1990 Phase 2|Phase 3
NCT00002462 European Organisation for Research and Treatment of Cancer - EORTC Lymphoma September 1989 Phase 3
NCT00618501 Asan Medical Center|National Cancer Institute (NCI) Leukemia October 2005 Phase 2
NCT00416832 Christine Mauz-Körholz|Martin-Luther-Universität Halle-Wittenberg Lymphoma November 2002 Phase 2
NCT00133991 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Leukemia|Lymphoma March 2005 Phase 2
NCT00070200 Children's Oncology Group|National Cancer Institute (NCI) Neuroblastoma March 2004 Phase 1
NCT00049595 European Organisation for Research and Treatment of Cancer - EORTC|Lymphoma Trials Office|Lymphoma Study Association|Grup per l'Estudi dels Limfomes de Catalunya i Balears|NCIC Clinical Trials Group|Australasian Leukaemia and Lymphoma Group|Nordic Lymphoma Group Lymphoma August 2002 Phase 3
NCT00041210 Mount Vernon Cancer Centre at Mount Vernon Hospital|National Cancer Institute (NCI) Lymphoma October 2001 Phase 3
NCT00030719 University of Leicester|National Cancer Institute (NCI) Neuroblastoma December 2001 Phase 3
NCT00025636 German Hodgkin's Lymphoma Study Group|European Organisation for Research and Treatment of Cancer - EORTC|EBMT Solid Tumors Working Party|National Cancer Institute (NCI) Lymphoma July 2001 Phase 3
NCT00019409 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Leukemia October 1999 Phase 3
NCT00002715 Stanford University|National Cancer Institute (NCI) Lymphoma April 1989 Phase 2
NCT00002714 Stanford University|National Cancer Institute (NCI) Lymphoma April 1995 Phase 2
NCT00002691 Memorial Sloan Kettering Cancer Center Lymphoma August 1995 Phase 2
NCT00002643 National Cancer Institute (NCI)|Children's Cancer Group Neutropenia|Sarcoma April 1995 Phase 2
NCT00002610 Children's Oncology Group|National Cancer Institute (NCI) Kidney Cancer January 1996 Phase 3
NCT00002516 University Hospital Muenster|Medical Research Council|National Cancer Institute (NCI) Sarcoma July 1992 Phase 3
NCT02723994 Incyte Corporation|Children's Oncology Group B-cell Acute Lymphoblastic Leukemia August 2016 Phase 2
NCT01156883 Gruppo Italiano Malattie EMatologiche dell'Adulto Leukemia April 2010
NCT01117441 University of Schleswig-Holstein|Deutsche Krebshilfe e.V., Bonn (Germany) Leukemia June 2010 Phase 3
NCT01085617 University College London Hospitals|National Cancer Institute (NCI) Leukemia|Mucositis|Oral Complications January 2010 Phase 3
NCT01005758 Ohio State University Comprehensive Cancer Center|National Cancer Institute (NCI) Leukemia January 2009 Phase 2
NCT00974792 Cancer Research UK|National Cancer Institute (NCI) Lymphoma January 2006 Phase 2
NCT00920153 French Innovative Leukemia Organisation Lymphoma May 2008 Phase 3
NCT00764907 University Hospital, Motol|National Cancer Institute (NCI) Leukemia November 2002 Phase 3
NCT00669812 Cancer Research UK|National Cancer Institute (NCI) Lymphoma|Small Intestine Cancer February 2008 Phase 2
NCT00574496 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lymphoma November 2007 Phase 2
NCT00558519 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Leukemia November 2007 Phase 2
NCT00550992 Dutch Childhood Oncology Group|BFM Germany|CORS Monza Italy|Associazione Italiana Ematologia Oncologia Pediatrica|Australian and New Zealand Children's Oncology Group|BFM Austria|CLCG France Belgium Portugal|COALL Germany|CPH, Czech republic|DFCI consortium USA|FRALLE France|Hong Kong|MD Anderson USA|NOPHO Scandinavian countries|PINDA, Chile|PPLLSG Poland|Seattle USA|SJCRH USA|UKCCSG United Kingdom Leukemia June 2007
NCT00526318 Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) Neuroblastoma January 2007
NCT00513188 University of Miami Lymphoma February 2007
NCT00458848 Gruppo Italiano Malattie EMatologiche dell'Adulto Leukemia October 2004 Phase 2
NCT00430118 University of Schleswig-Holstein Leukemia July 2000 Phase 3
NCT00417053 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Neuroblastoma Phase 3
NCT00410631 Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) Neuroblastoma October 2004 Phase 3
NCT00400946 Dana-Farber Cancer Institute|National Cancer Institute (NCI) Drug/Agent Toxicity by Tissue/Organ|Leukemia April 2005 Phase 3
NCT00379457 European Paediatric Soft Tissue Sarcoma Study Group|Italian Association for Pediatric Hematology Oncology|Children's Cancer and Leukaemia Group|Dutch Childhood Oncology Group|National Cancer Institute (NCI) Sarcoma June 2006 Phase 3
NCT00343369 Universitätsklinikum Hamburg-Eppendorf|National Cancer Institute (NCI) Leukemia January 2003
NCT00303810 Universitätsklinikum Hamburg-Eppendorf Brain and Central Nervous System Tumors January 2001
NCT00275106 Children's Cancer and Leukaemia Group|European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma|National Cancer Institute (NCI) Lymphoma September 2004 Phase 3
NCT00238368 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Lymphoma February 2004 Phase 2
NCT00080925 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms February 2004 Phase 1
NCT00077285 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Sarcoma October 2003 Phase 2
NCT00060385 European Organisation for Research and Treatment of Cancer - EORTC Lymphoma March 2003 Phase 2|Phase 3
NCT00040872 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Neuroblastoma June 2000 Phase 2
NCT00040690 Medical Research Council|National Cancer Institute (NCI) Leukemia|Lymphoma November 2008 Phase 2
NCT00032019 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma February 2002 Phase 2
NCT00028886 Commissie Voor Klinisch Toegepast Onderzoek|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm March 2001 Phase 3
NCT00025649 European Infant Neuroblastoma Study Group - 1999|National Cancer Institute (NCI) Neuroblastoma July 1999 Phase 2
NCT00025441 Societe Internationale d'Oncologie Pediatrique|Children's Cancer and Leukaemia Group|Societe Francaise Oncologie Pediatrique|National Cancer Institute (NCI) Ovarian Cancer|Sarcoma|Small Intestine Cancer November 1998 Phase 2
NCT00025103 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Kidney Cancer May 2001 Phase 2
NCT00024193 Children's Cancer and Leukaemia Group|Societe Francaise Oncologie Pediatrique|National Cancer Institute (NCI) Neuroblastoma April 1999 Phase 2
NCT00022126 Children's Oncology Group|National Cancer Institute (NCI) Leukemia November 2002 Phase 2
NCT00020943 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma June 2001 Phase 2
NCT00018954 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Leukemia|Lymphoma October 1992 Phase 2
NCT00017368 Children's Oncology Group|National Cancer Institute (NCI) Neuroblastoma April 2001 Phase 2
NCT00017225 Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) Neuroblastoma May 1997 Phase 2
NCT00006669 Washington Hospital Center|National Cancer Institute (NCI) Lymphoma September 1999 Phase 2
NCT00005603 Children's Oncology Group|National Cancer Institute (NCI) Leukemia March 2000 Phase 3
NCT00004231 Northwestern University|National Cancer Institute (NCI) Lymphoma October 1999 Phase 2
NCT00004197 University of Nebraska|National Cancer Institute (NCI) Lymphoma June 1999 Phase 2
NCT00003815 Scotland and Newcastle Lymphoma Group|National Cancer Institute (NCI) Lymphoma June 1994 Phase 3
NCT00003728 European Organisation for Research and Treatment of Cancer - EORTC|National Cancer Institute (NCI) Leukemia|Lymphoma December 1998 Phase 3
NCT00003700 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Leukemia January 1999 Phase 2
NCT00003650 UNICANCER|National Cancer Institute (NCI) Lymphoma June 1998 Phase 3
NCT00003578 Lymphoma Trials Office|National Cancer Institute (NCI) Lymphoma January 1993 Phase 3
NCT00003541 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lymphoma June 1998 Phase 1|Phase 2
NCT00003437 Medical Research Council|National Cancer Institute (NCI) Leukemia January 1997 Phase 3
NCT00003423 United Kingdom Children's Cancer Study Group|National Cancer Institute (NCI) Lymphoma May 1995 Phase 3
NCT00003273 New York University School of Medicine Brain and Central Nervous System Tumors|Neuroblastoma|Retinoblastoma|Sarcoma November 1997 Phase 2
NCT00003262 Centro di Riferimento Oncologico - Aviano|National Cancer Institute (NCI) Lymphoma May 1997 Phase 2
NCT00003215 Swiss Group for Clinical Cancer Research Lymphoma April 1997 Phase 3
NCT00002865 Wake Forest University Health Sciences|National Cancer Institute (NCI) Leukemia April 1995 Phase 2
NCT00002835 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Lymphoma July 1995 Phase 3
NCT00002802 Children's Hospital Medical Center, Cincinnati|National Cancer Institute (NCI) Neuroblastoma July 1990 Phase 3
NCT00002785 Children's Oncology Group|National Cancer Institute (NCI) Leukemia July 1996 Phase 2
NCT00002757 Children's Oncology Group|National Cancer Institute (NCI)|Societe Francaise Oncologie Pediatrique|Children's Cancer and Leukaemia Group Leukemia|Lymphoma June 2001 Phase 3
NCT00002756 Children's Oncology Group|National Cancer Institute (NCI) Leukemia June 1996 Phase 2
NCT00002704 National Cancer Institute (NCI) Leukemia January 1996 Phase 2
NCT00002700 European Organisation for Research and Treatment of Cancer - EORTC|Acute Leukemia French Association Leukemia|Lymphoma August 1995 Phase 3
NCT00002676 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma July 1995 Phase 2
NCT00002665 Southwest Oncology Group|National Cancer Institute (NCI) Leukemia|Neutropenia|Thrombocytopenia July 1995 Phase 2
NCT00002599 Medical Research Council|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm September 1994 Phase 3
NCT00002531 Johann Wolfgang Goethe University Hospital|National Cancer Institute (NCI) Leukemia January 1993 Phase 2
NCT00002524 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Lymphoma June 1993 Phase 2
NCT00002514 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Medical Research Council Leukemia April 1993 Phase 3
NCT00002494 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Leukemia|Lymphoma May 1992 Phase 2
NCT00002489 Memorial Sloan Kettering Cancer Center Extragonadal Germ Cell Tumor|Ovarian Cancer October 1991 Phase 2
NCT00002471 Memorial Sloan Kettering Cancer Center Leukemia|Lymphoma February 1990 Phase 2
NCT00199056 Johann Wolfgang Goethe University Hospital Adult Acute Lymphocytic Leukemia October 1999 Phase 4
NCT00199082 Nicola Goekbuget|Johann Wolfgang Goethe University Hospital Burkitt's Lymphoma|Burkitt's Leukemia|Mediastinal Neoplasms|Lymphoblastic Lymphoma|Large Cell Anaplastic Lymphoma July 2002 Phase 4
View MoreCollapse
References
Preparing Stock Solutions
Concentration Volume (DMSO) Mass 1 mg 5 mg 10 mg
1 mM 1.0834 mL 5.4169 mL 10.8338 mL
5 mM 0.2167 mL 1.0834 mL 2.1668 mL
10 mM 0.1083 mL 0.5417 mL 1.0834 mL
Cell Assay
[1]

Cells are plated in 2 mL of medium in 35 mm plates at a concentration of about 5×104 cells/mL and grow for 24 h at 37°C in an atmosphere of 5% CO2 and 95% air. Then medium is replaced with fresh medium lacking or containing 4 nM drug and proliferation is continued for 3 days. Cell counts are done each day in a Coulter Counter after detaching the cells with trypsin and EDTA. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

References
Molecular Weight

923.04

Formula

C₄₆H₅₈N₄O₁₄S

CAS No.

2068-78-2

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Shipping

Room temperature in continental US; may vary elsewhere

Solvent & Solubility

10 mM in DMSO

Vincristine solution (dissolved with acetone) is mixed with PLGA solution[6].

* "<1 mg/mL" means slightly soluble or insoluble. "≥" means soluble, but saturation unknown.

References

Purity: 99.40%

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number

 

Organization name *

Country *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Vincristine sulfate
Cat. No.:
HY-N0488
Quantity: